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Abstract
This work reports on the psychometric properties of a new measure designed to screen
for distress in large populations of cancer patients. The Distress Thermometer (Holland et aI.,
2000) was tested in a group of 239 heterogeneously diagnosed cancer patients. It was found to
be internally consistent (~ = 0.86) and to exhibit a reliable eight-factor solution. It displayed
acceptable concurrent validity (2':::: 0.0001) when compared to the Rotterdam Symptom
Checklist (deHaes et aI., 1994), the Functional Living Index Cancer (Schipper et aI., 1984) and
the Brief Symptom Inventory (Derogatis, 1993). It was also found to be a sensitive measure of
subsyndromal distress.
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Introduction

A cancer diagnosis often leads to an existential crises (Weisman & Worden, 1976-77). In the
philosophical sense this crises may be replete with 0ppOliunities to acknowledge the mortal
nature of human

~xistence

and to construct a more authentic life (Bolmsjoe, 2000). In terms of

psychological experience the distress that accompanies the crises adds to suffering associated
with the disease (Baider & DeNour, 1977; Foley, 1999; Holland, 1997), to its morbidity (Fawsy,
1994; Holland, Lloyd, 1979; McDaniel, Musselman, Porter, Reed & Nemeroff, 1995), and
perhaps, to its mortality (Derogatis, Abeloff & Melisaratos, 1979; Faller, Bulzebruck, Drings &
Lang, 1999; Fawsy, Morrison & Paffenbarger, 1981).

Problem Statement and Purpose of the Study

Problem.

In 2001some 1,268,000 Americans received a new cancer diagnosis and 553,4000 died
from the disease (American Cancer Society, 2001; ACS). A seminal study (Derogatis, et al.,
1983) finds that 47% of those with cancer diagnoses will experience distress sufficient to
increase the disease's morbidity. Later studies estimate the prevalence of psychological
morbidity in cancer populations to range from 48.2% (Chochinov, Wilson, Enns & Lander,
1994) to 0% (Roberts, Rossetti, Cone & Cavanaugh, 1992) depending on the population studied
and the criteria used. (See section entitled "Prevalence of Psychiatric Diagnoses in Cancer
Populations" for further discussion.) The atmual cost associated with cancer's morbidity is
estimated to be $180.2 billion (ACS). Untreated distress accrues cost both in terms of the loss
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of the quality of cancer patients' lives and of their health care. The development of a pragmatic
and sensitive way to diagnosis distress in the cancer population is the first step toward reducing
untreated distress. It is a key initiative in the psycho-oncology community (Foley, 1999;
Holland, 1997; Holland, Foley, Handzo, Levy & Loscalzo, 1999). The Distress Thermometer
(DT) (Holland, et'lil., 2000; see Appendix A) is a linear analogue scale that is likely to help
meet this initiative. The Distress Thermometer's reliability and validity as a measure of distress
in cancer populations has not been established.

Purpose.

The purpose of this study was to describe some of the DT's (Holland et al., 2000)
psychometric properties in a sample of cancer patients. The scale's internal consistency and
factor structure was examined. Its performance was compared to three established measures of
aspects of distress in cancer populations: the Rotterdam Symptom Inventory (RSI) (deHaes, van
Knippenberg, & Neijt, 1990; see Appendix B), the Functional Living Index Cancer (FLIC)
(Schipper, Clinch, McMurray & Levitt, 1984; see Appendix C), and the Brief Symptom
Inventory (BSI) (Derogatis, 1993; Derogatis, Dellapietra, & Kilroy, 1992; see Appendix D).

Problem Parameters

Complex issues that impede the diagnosis of the full spectrum of distress in cancer
popUlations have been widely discussed (Barg, Cooley, Pasacreta, Senay & McCorkle, 1994;
Bieliauskas & Garron, 1982; Coyle, Layman-Goldstein, Passik, Fishman & Portenoy, 1996;
Foley, 1999; Holland, 1997; McDaniel et al., 1995; O'Boyle & Waldron, 1997; Portenoy,
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Thaler, Kornblith, McCarthy-Lepore, Friedlander-KIaI', Coyle et aI., 1994; Valente, Saunders &
Zichi-Cohen, 1994). This discussion is summarized below.
First, the literature indicates that routine psychosocial assessment in cancer populations
does not occur. Cancer patients and their families often report that their psychosocial needs are
not met. In the 80s tw6 surveys were commissioned by the Cancer Control Advisory Board of
the Pennsylvania Department of Health (Houts et aI., 1988; Houts, Yasko, Kahn, Schelzel &
Marconi, 1986). The goals of the surveys included descriptions of the umnet needs of cancer
patients during the first year after diagnosis and in the terminal period. Results indicated that
59% of cancer patients in PelIDsylvania have at least one unmet need in the year following
diagnosis (Houts et aI., 1988; Houts et aI., 1986). The need for assistance with emotional issues
that accompany the disease was the most frequently reported unmet need. In the terminal phase,
72% of the surveyed patients identified unmet needs. The two most frequently cited were
insufficient help with physical problems and lack of assistance to ameliorate emotional issues
associated with the disease (Houts, et aI., 1988). Clinical reports (Holland, 1997) verify that
patients consider provision of services that meet their emotional needs to be an important part of
their care. Forty-four percent of the recipients of the results thought that lack of psychosocial
assessment lead to neglect of the patients' emotional needs (Houts et aI., 1988). Cull, Steward
and Altman (1995) conclude that many institutions have no policy requiring that cancer patients
be screened for emotional issues. Adding to the challenge, neither psychological screening nor
psychological services are among the criteria that an institution must meet to be designated a
comprehensive cancer center for research purposes (McQuellon, Hurt, & DeChatelet, 1996).
The second issue that hampers psychosocial assessment in cancer populations has been
described as a lack of correlation between the physicians' perceptions and the patients' actual
level of psychosocial functioning. An initial study of 23 cancer patients and their primary
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physicians reported that physicians' estimations of the patients' emotional distress correlated
poorly with the patients' self-reports (Derogatis, Abeloff & McBeth, 1976). Physicians tended
to overestimate patients' levels of anxiety while underestimating their levels of depression.
Later studies (Ford, Fallowfield & Lewis, 1994; Monahan, 1988; Sollner, Zingg-Schir,
Rumpold, Mairinger & Fritsch, 1998) report similar results. Researchers also found that the
proficiency of physicians' ratings varies among patients (Sollner et al.) and that some
physicians are consistently more proficient than others in describing their patients' emotional
states and quality oflife (Ford et al.). Even the best correlations between the physicians'
estimation of emotional distress and the patients' self reports are moderate (Ford et al.;
Stephens, Hopwood, Girling & Machin, 1997). In some cases a negative relationship between
the physician's perceptions and the patient's report exists (Ford et al.; Sollner et al.). This
research points to the conclusions that many physicians misperceive patients' emotional state
and often underestimate the amount of distress patients are experiencing. For example, Holland
(1997) claims that 51 % of the cancer patients at Memorial Sloan Kettering Hospital have
symptoms that are congruent with a psychiatric diagnosis, especially anxiety or depression, and
that most psychiatric symptoms go unrecognized.
In a review of the literature, Valente, Saunders and Zichi -Cohen (1994) suggest that
myths account for some of the disparity between patients' estimates of emotional distress and
those of their physicians. These myths include the following topics: (a) a consensus among
health care providers that affective distress and perhaps even suicide contemplation are
understandable and expected reactions to a cancer diagnosis and therefore do not require
treatment; (b) professionals' proclivity to worry that responding to affective problems is too
time consuming; and (c) common beliefs that cancer patients' affective symptoms are really
lack of motivation, laziness and/or noncompliance.

Validation Distress Thermometer

5

After studying the psychiatric morbidity in a sample of 117 cancer patients receiving bad
news, Ford, Lewis & Fallowfield (1995) agreed that poor patterns of identification of cancer
patients in need of psychological follow-up are related to the reluctance of both patients and
physicians to discuss psychological issues. They also suggested that the belief that distress and,
thus distress assessment, should be confined to certain points on the disease trajectory
constituted an additional widely held myth. For example, distress may be thought to be
problematic exclusively at times when bad news is received or when the disease leads to a
terminal outcome. Despite this evidence, many physicians continue to hold the view that they
are proficient at identifying distress (Fallowfield, Ratcliffe, Jenkins & Saul, 2001).
Another issue that interferes with proper assessment is that distress often becomes
problematic in cancer populations before its symptoms reach the threshold criteria for a
psychiatric diagnosis (Holland et aI., 2000; Holmes, 1991). This presents a unique problem for
psychosocial assessment in oncology because cutoff scores and instruments used to confirm a
psychiatric diagnosis may not be sufficiently sensitive to detect distress in cancer populations.
Reviews of the literature conclude that subclinical emotional distress is common in cancer
populations and differs from major mood disorders not only in level of severity, but also in the
breadth of symptoms described (Sollner, et aI., 1998; Tope, Ahles & Silberfarb, 1993).
Although the symptoms often do not amount to a psychiatric diagnosis, they cause "significant
islands oflife disruption" (Tope, p.1 02). Roberts, Rossetti, Cone and Cavanaugh's (1992) study
of 32 cancer survivors demonstrates this sub-clinical disruption. Although 31 of the 32 subjects
reported unmet needs for psychological services, 100% of the study subjects scored well below
all criteria necessary for the diagnosis of emotional illness and all reported good quality-of- life
scores. Therefore, the subjects were distressed by their own repOli but not emotionally ill.
Rhodes, McDaniel, Homan, Johnson, & Madsen, (2000) compared a sample of 175 oncology
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patients with 82 patients with other medical concerns that included elective surgery; acute
conditions such as myocardial infarction or cholecystitis; or exacerbation in chronic conditions;
such as diabetes mellitus or chronic obstructive pulmonary disease. This study did not try to
establish psychiatric diagnoses, but the authors found that the cancer population reported
significantly more distress than the medical-surgical population. Even a subclinical level of
distress associated with cancer symptoms had a profound impact on the quality of life for 243
cancer patients with heterogeneous diagnoses (Portenoy, et aI., 1994). Holland (1997) calls this
level of distress "subsyndromal" and proposes that distress screening occur for all cancer
patients so that appropriate interventions might be delivered. A complete psychiatric screening
may follow distress screening, if indicated for individual patients.
If an instrument were sensitive enough to diagnose subsyndromal distress, and
administratively practical, then high-risk individuals might be identified and the unrealistic goal
of treating all cancer patients as if they were at high risk for distress (Barg, et aI., 1994)
modified. The issue of clinical practicality frames standards for a viable screening tool. Roth et
al. (1998) call attention to the recent movement of cancer care from a primarily inpatient arena
to outpatient practices. This resulted in fewer professional person-hours per patient and made
the press for a rapid means of identifying distressed patients more important than in previous
decades.
A number of other barriers impede routine screening for distress in large cancer
populations. In reviewing the literature, Sollner and colleagues (1998) concluded that although
the clinical interview is the gold standard for establishing distress, it is too administratively
demanding to use for routine screening. Some well-respected paper and pencil tools like the
Minnesota Multiphasic Personality Inventory (Butcher, 2000) and the Symptom Checklist-90
(Derogatis & Savitz, 1999) are self-administered. However, they are also burdensome because
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of the costs associated with the purchase of the testing and scoring equipment for ongoing large
populations and the personnel time required for scoring, interpretation and reporting (Derogatis,
1993). Additionally, many cancer patients who fatigue easily find the exercise of completing
lengthy self-reports unacceptable (Holland et aI., 2000).
Holland's (1997) position paper summarizes some of the previously discussed hurdles to
distress screening and evaluation in cancer populations. She draws on many years of psychooncology experience to reach three conclusions. First, physician attitudes often interfere with
effective screening for distress. Second, the continuum of problematic emotional experience in
cancer differs from psychiatric diagnoses, and screening for psychiatric diagnoses often misses
many emotional problems associated with cancer. Third, the administrative burden associated
with some measures prevents their use for screening in large cancer populations in time
constrained health care settings.

Criteria for Distress Assessment in Medical Settings

Given the interest in improving distress assessment, researchers have reviewed the
literature (Finlay & Dunlop, 1994; Grant, Padilla, Ferrel & Rhiner, 1990) and convened a panel
of experts (Barg, et aI., 1994) to define the requirements for a screening tool to be used in
oncology settings. As a result, criteria against which to judge the utility of an instrument for
measuring distress in oncology were constructed. The defined criteria listed below propose that
the instrument should be: (a) specific for cancer (Barg; Finlay; Grant); (b) self-administered and
easily interpretable by professional level staff without special training (Barg; Finlay; Grant); (c)
amenable to re-test (Finlay); (d) sensitive enough to identify people at risk for psychosocial
problems (Barg; Finlay, Grant); (e) short and should not contribute to response burden (Barg;
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Finlay); (f) tied to a triage and referral system (Barg); and (g) designed to identify problems in
multiple dimensions (Barg).
Most available distress screening instruments fail to meet some of these criteria (See
section entitled "Distress Screening Tools" for a review of screening instruments). The Distress
~ '< '

Thermometer meets these criteria and may prove to be a viable initial screening tool in large
cancer populations. Subsequent sections of this work define distress within the problem-coping
framework, and review the current literature on the prevalence of and risk for distress in the
general cancer population. The current methods of distress assessment in cancer populations
are then reviewed and critiqued. The Distress Thermometer (National Comprehensive Cancer
Network [NCCN], 2000) is then described. This description is followed by the results of a
research project conducted to examine its reliability and validity in a sample of cancer patients.
The final section discusses and draws conclusions from the study.

Definitions of Distress

Popular Definition.

Distress is a natural concept with popular definitions. These definitions are:
When used as a verb it means to cause sorrow, misery, or suffering; to
make unhappy, anxious, etc.; pain; afflict; trouble. When used as a noun
it means the state of being distressed; pain; grief; anxiety; suffering or
anything that distresses; affliction or a state of danger or trouble; bad
straits. It implies mental or physical strain imposed by pain, trouble,
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worry or the like and usually suggests that the state can be relieved.
(Webster's New World Dictionary of the English Language, 1968, p. 330)

Conceptual Definitions.

In the cancer literature the term "distress" is defined in at least three ways depending
upon the framework within which it is conceptualized. In the first iteration, many authors refer
to psychosocial distress or emotional distress as general terms for any psychiatric diagnosis or
positive result in psychological testing in a cancer population (Akechi, et aI., 2000; Baider &
DeNour, 1997; Bredart, et aI., 1999; Farber, Weinerman & Kuypers, 1983; Kugaya, Akechi,
Okuyama, Okamura & Uchitomi, 1998; McQuellon et aI., 1998; Passik, Newman, Brennan &
Tunkel, 1995; Sollner et aI., 1998). This psychiatrically based definition may correctly apply to
a subset of the cancer population whose symptomatology meets guidelines for emotional illness.
It also may result in incorrect clinical conclusions as the symptoms that lead to psychiatric

diagnosis like fatigue, anorexia, irritability and disturbed cognitive processes also result from
cancer pathology and!or treatment agents (Valente, Saunders & Zichi -Cohen, 1994).
In the second conceptual framework either the term "distress" or the phrase
"psychological distress" is used either to describe the emotional dimension of a
multidimensional quality oflife construct that is applied to the cancer experience (O'Boyle &
Waldron, 1997; Roberts et aI., 1992; Schag, Ganz & Heinrich, 1991; Schag & Heinrich, 1990;
Schag, Heinrich & Aadland, 1990; Schag, Heinrich & Ganz, 1984; Zabora et aI., 1997) or to
indicate lack of quality of life (Coyle et aI., 1996). From this perspective, distress is the
opposite of well being (McQuellon et aI., 1996) and well being is one component of quality of
life (Tope et aI., 1993). Emotional symptoms are one of a large number of varying determinants
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of well being. The quantification of the symptoms of distress and the degree of impact on the
total quality of life varies greatly among instruments used to measure quality of life in cancer
patients (Grant et at., 1990).
In the third framework, distress is a subjective, sometimes disabling symptom that
occurs because of an inability to solve or cope with the problems associated with the experience
of having cancer and with cancer treatments (Holland, 1997; Nezu, Nezu, Friedman, Faddis &
Houts, 1998; Peruselli et at., 1993; Portenoy, Thaler, Kornblith, McCarthy-Lepore, FriedlanderIGar, Coyle, et at., 1994; Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar,
Kiyasu et at., 1994; Rhodes, McDaniel, Homan, 10hnson & Madsen, 2000; Roth et at., 1998).
This third locus of interest is the most pragmatic from a clinical viewpoint. It enables clinicians
to narrow attention to particular problems within a quality of life framework and accepts that no
single phenomena are universally associated with distress. A phenomenon causes distress if,
and only if, the client cannot cope with it. Therefore, distress is not a syndrome easily
measured against external criteria (like the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, 1998; DSM-IV), but rather, is gauged by the client's subjective
experience.

NCCN Definition.

The NCCN (1998) a consortium of 18 nationwide leading cancer centers, has met
annually for the past six years. The members of the network agreed upon a problem-coping
conceptualization with distress defined as an unpleasant reaction to problems in psychological,
social, physical or spiritual domains associated with having cancer. Specifically, they define
distress in cancer as:
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An unpleasant emotional experience of a psychological (cognitive, behavioral,
emotional), social, and/or spiritual nature that may interfere with the ability to cope
effectively with cancer and its treatment. Distress extends along a continuum, ranging
from common normal feelings of vulnerability, sadness, and fears to problems that can
become disabling, such as depression, anxiety, panic, social isolation, and spiritual
crisis. (NCCN, 2000, p. DIS-2)

Advantages of the NCCN Definition.

The committee chose the term "distress" to define the emotional reactions associated
with cancer, as it is acceptable to both patients and health care providers in a medical setting for
at least three reasons. It removes the stigma of psychiatric, psychosocial, and emotional
references from the patient care equation. It is framed in terms of normal and excessive
reactions and is less embarrassing than words describing a breach in mental health. Last, it can
be defined by self-report (NCCN, 2000). Holland (1997) observes from her clinical perspective
that anything related to the mental domain carries a stigma and words such as emotional,
behavioral, psychological and psychiatric offend oncology patients, while the word distress
implies normal to severe feelings expressed by people with cancer as they face personal and
illness-related issues.
Additionally, the NCCN (2000) definition of distress is congruent with a large body of
literature (Coyle et ai., 1996; deHaes et ai., 1990; Hurny et ai., 1993; McCorkle & Young,
1978; O'Boyle & Waldron, 1997; Peruselli, et ai., 1993; Rhodes et aI, 2000; Schag, et ai., 1991;
Schag & Heinrich, 1990; Schipper et ai., 1984; Sollner et ai., 1998) in its multiaxial format,
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trait-like rather than state-like concept of distress and choice of self-report as the measure of
presence, intensity and cause of distress.

important Concepts in the Definition of Distress.

The multi axial focus for the definition of distress became important in cancer
populations as chronicity increased and the boundaries among physical, emotional, social and
functional issues' impact on the cancer experience blurred. Table 1 summarizes the dimensions
that have often been associated with distress in cancer populations. Most universally, deficits in
physical functioning, including somatic symptoms, problems with psychological and/or social
function and practical issues are thought to be sources of distress. It is essential that a
multiaxial assessment include all four dimensions.
The experience of distress in cancer populations is partially related to the disease's
exacerbations and remissions and to changes in its treatment and treatment response (Zabora et
aI., 1997). It is also influenced by the client's pre-illness level of able functioning and emotional
history (Massie & Holland, 1990). A percentage of cancer patients have problems with family
dynamics, under-employment, are poor and may have legal problems (Holland et aI., 1998).
The imposition of a cancer diagnosis changes the experiential pattern (Weisman & Worden,
1976-77), it may increase distress related to new problems and sometimes decreases distress in
other areas. This points to the need for a trait-like, as opposed to state-like definition of
distress. The NCCN (2000) inclusion of the concept of a continuum of experience is congruent
with the trait conceptualization. Cull, Stewart and Altman (1995) observe that most of the
patients in their routine oncology practice present with transient distress. Other expelis reached
similar conclusions. For example, Pruitt, Waligora-Serafin, McMahon and Davenport (1991)
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found that distress in a general cancer population decreased when measured both at 3 and 6
months after the initial diagnosis. Lloyd (1979) analyzed the literature and found that the stage
at which an emotional response to cancer is considered morbid is arbitrar
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Table 1
Variables Associated With Distress in Cancer Populations
1

2

1. Structured Interview (Coyle et aI., 1996)

X

X X

2. Rotterdam Symptom Checklist (deHaes et aI., 1990)

X

X

X

3. Functional Living Index Cancer (Schipper et aI., 1984)

X

X X

X

Tool (Authors)

4

5

X

X X

6

X

10

11

12

13

14

15

16

X

X

X

X

X

X

X

X
X

X X

4. Perceived Adjustment to Chronic Illness Scale (Hurny et ai., 1993)
5. Review (O'Boyle & Waldron, 1997)

3

X X X X
X X

X

6. Symptom Distress Scale Italian Version (Peruselli, et aI., 1993),

X

American version (McCorkle & Young, 1978)
7. Memorial Symptom Assessment Scale (Portenoy, Kornblith,

X

X X

X

X

McCarthy-Lepore, Friedlander-Klar, Coyle et aI., 1994; Portenoy,
Kornblith, McCarthy-Lepore, Friedlander-Klar, Kiyasu et ai., 1994)

X

8. Adapted Symptom Distress ScaIe-2 (Rhodes et aI, 2000)
9. Distress Thermometer (Roth et aI., 1998)
10. Cancer Rehabilitation Evaluation System and Cancer Rehabilitation
System- Short Form (Schag et aI., 1991; Schag & Heinrich, 1990)
- -

X

X X

X

X X

X X

X
X

X

Tool (Authors)

1

2

11. Hospital Questionnaire (Sollner et ai., 1998)

X

X X X

3

4

5

-----

1= Physical FunctlOnmg

10= Sexual FunctlOnmg

2= Psychological Functioning

11= Somatic Symptoms

3= Social functioning

12= Occupational Functioning

4.=Financial and Material Well-being

13=Recreational Functioning

5= Overall discomfort

14=Satisfaction with Treatment

6=Treatmetn Toxicity

15=Health Status

7=Body Image

16=Future Prospects

8=Informational Functioning
9=Functional Status

6
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10

11

12

13

X

X

14
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O'Boyle and Waldron's (1997) conceptual analysis of quality of life in cancer
populations finds that the impact of a particular problem on an individual patient's subjective
experience of distress cannot be predicted. This trait-like definition of distress does not
preclude the interaction between more stable personality variables and distress in the cancer
experience. For example, researchers (Evans, Baldwin & Garth, 1974) find that individuals
with mental illness are five times more likely to develop cancer than the normal population.
Although not researched, it is reasonable to conclude that in this sub-population, the distress
level may remain elevated throughout the course of the disease.
Last, the NCCN definition accepts the consensus that distress is a subjective experience
and only the patient can estimate the level of distress and communicate this level by self-report.
Peruselli and colleagues (1993) and others (Holmes, 1991; Monahan, 1988) agree that distress
refers to the amount of discomfort caused by a specific symptom as perceived by the patient.
Holmes (1991) defines distress in cancer as the degree of discomfort from a specific symptom
as perceived by the patient. Rhodes and colleagues (2000) explain that in order for distress to
exist, the individual must be aware of the tension created by the problem and the degree of
mental anguish associated with it. Although self-report may be subject to faking good or faking
bad, and information that may be probed on interview missed, it is the only window to the
patient's subjective experience (Derogatis, 1993). Further, self-report avoids the expense and
administrative burden associated with interview (Derogatis; Finlay & Dunlop, 1994) and can be
administered by paraprofessional staff (Derogatis). The self-report is also highly amenable to
actuarial methods of scoring and interpretation (Meehl & Dalstrom, 1960) and is easily
transportable (Derogatis). It is used by a large number of researchers to measure distress (Barg
et aI., 1994; Ganz et aI., 1993; POlienoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar,
Coyle et aI., 1994).
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The Distress Thermometer was developed to measure distress as defined by the NCCN
(2000). In subsequent sections, the NCCN definition of distress will be used. In contrast, the
terms "emotional illness", "psychiatric diagnosis" or "mental illness" are used to refer to
conditions that meet DSM-IV (American Psychiatric Association; APA, 1994) diagnostic
criteria.

Additional Definitions

Cancer.

Anyone of more than 200 diseases involving disorganized abnormal cells that do not
abide by the ordinary complex regulation that governs cellular reproduction, survival and death.
These cells are not restricted to an anatomical location as are normal cells, nor do they reach a
specified size and stop growing as normal tissues does. They cause symptoms by interfering
with normal cellular and tissue functioning (Holland et aI., 1998)

Quality of life.

Quality oflife is an individual's subjective sense of well being derived from his or her
current experience of life (Tope et aI., 1993). It is either general, referring to education,
aesthetic experience and socioeconomic status, or health related and illness specific (O'Boyle &
Waldron, 1997).

Validation Distress Thermometer
Functional status.

Ability to independently accomplish activities that could be accomplished by the
majority of healthy adults in any given culture (Schipper et aI., 1984).

Coping.

Ability to change either the internal (thoughts, feelings) or external environment
(behaviors, relationships, tangible environmental factors) so in order to produce eustress
(Lazarus, 1995).

Theoretical Background

The multiaxial focus and tension between physical or environmental presses and
emotional symptoms that characterize the proposed understanding of distress are based on the
neobehavioral, mulitmodal work of Lazarus (1995) and Lazarus and Folkman (1989).
Arnold Lazarus (1995) proposes that our personalities stem from interplay among our
genetic endowment, our physical environment and our social learning history. He does not
accept the basic social learning triad of classical conditioning, operant conditioning and
observational learning as explanatory for behavior changes. Instead he proposes that people
respond to their perceived environment including their personal use of language, expectancies,
selective attention, goals, attitudes, attributions and beliefs to produce behavior. If Lazarus is
correct, then the experience of cancer becomes an attribute of both the internal and external
environments, and the cognitive and emotional processes associated with it partially determine
the cancer patient's behaviors.

18
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Lazarus (1995) believes that in the course of being exposed to various situations people
may acquire conflicting information, faulty cognitions and needless defenses. Emotional
problems arise when individuals lack the necessary information and essential coping processes
to handle situational demands.
Folkman's (1984) extension of Lazarus's theory to health stressors began when she
analyzed the role of personal stress and coping processes with health problems within the
multimodal framework. Folkman applied a multimodal theoretical formulation of stress and
coping to demonstrate the complexities of the perception of control over health events. She
examined how the belief that one has control over health-related situations may increase threat,
the relationship between control and coping, and the pathways through which control affects the
adaptation to stressful encounters.
Folkman also worked with Richard Lazarus and his associates (Folkman, Lazarus,
Gruen & DeLongis, 1986) to examine the relationships among personality factors (mastery and
trust), primary appraisal (the stakes an individual holds in a stressful situation), and secondary
appraisal (the options for coping on the situation) in eight forms of problem- or
emotion-focused coping, and physical health status and psychological symptoms. They found
that the cognitive and behavioral coping strategies used across stressful situations were highly
variable while the emotional forms of coping were more stable across situations. The
personality factors, primary appraisal and coping variables accounted for a large amount of the
variation in psychiatric symptoms, but were not related to physical health status. This suggests
that distress levels may change as a function of personality, primary appraisal and coping
strategies.
In 1988, Folkman and Lazarus challenged the traditional assumption held by many
health care providers that coping affects emotion. They proposed instead that the individual's
emotional state influences coping choices. In testing this hypothesis in a sample of 75 married
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couples, they discovered that some forms of coping are associated with increased positive
emotions while other forms of coping are associated with increased negative emotions. This
finding suggests that coping choices and emotion are interactive. With respect to distress, this
tenant suggests that distress both influences and is influenced by coping choices.
Later in the same year, the investigators (Lazarus & Folkman, 1989; Folkman &
Lazarus, 1990) argued that coping mediates emotion in a process that involves at least three
mechanisms: a) cognitive activity that directs attention; b) alteration and interpretation of the
subjective meaning of an encounter or situation; and c) actions that alter the person-environment
relationship. In this study, coping was found to mediate emotional responses in a sample of75
married couples. Authors concluded that emotions and coping processes change as the subject's
perceptions of and reactions to specific situations change. In accordance, it is likely that distress
in cancer populations changes in specific situations and is inversely related to coping
effectiveness.
Of interest to the discussion, the same theoreticians also proposed and demonstrated that
central hassles or ongoing themes and problems in an individual's life have a greater ability to
define needs and to reveal deficits in coping skills than non-central issues (Gruen, Folkman &
Lazarus, 1988). Psychological symptoms were found to be more highly associated with central
hassles than non-central issues. A diagnosis of cancer might be a central issue for some people.
In such cases, the diagnosis is likely to be associated with psychological symptoms or distress.
The central issue theory is congruent with the conceptualization of distress as an
emotional symptom related to a failure in coping strategies for situation specific problems in the
central hassle of a cancer diagnosis. Distress, worsened by coping failure, may further impede
effective coping (Gruen, Folkman & Lazarus, 1988; Nezu et aI., 1998). Consequently, distress
measurement offers a vehicle for discrimination between cancer patients with adequate coping
and euphoric emotional responses and those with poor coping and disphoric emotional
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responses. When distressed patients are identified, interventions that prevent further emotional
decompensation can be appropriately directed.

Review of the Literature and Related Research

Scope of the Review.

The contextual understanding of relationships among emotional issues in general and the
'cancer experience spans the literature of Western civilization (Hollandet al., 1998). The
literature that informs our understanding about the concept of distress and its measurement in
cancer populations by comparison is in its infancy. Since distress and psychiatric symptoms are
related on a continuum, the most relevant clinical literature concerns the prevalence of
emotional illness in cancer populations, the prevalence of distress in cancer populations and the
risk profile for distress in cancer populations. Directly related research focuses on the efforts to
develop instruments to screen for distress in cancer cohorts. The bodies of literature that
address the prevalence of psychiatric symptoms and distress in cancer populations and the risk
factors for distress in cancer popUlations are reviewed in this section.

Limitations of the Review.

Although conceptually interesting, three large areas of tangentially related to the concept
of distress in the literature are excluded from the review. The following topics are excluded:
(a) The broad body of literature that discusses or demonstrates links among distress/emotional
factors and the incidence, progression and survival time associated with cancer (Le., Bieliaukas
& Garon, 1982; Derogatis et al., 1979; Faller et al., 1999);
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(b) The literature that addresses the relationships among distress and immune function in cancer
populations (i.e., Fawsy, 1994; Fawsy, et aI., 1990); (c) The relationship between premorbid
personality and levels of emotional illness/distress and the development of cancer (i.e., Dattore,
Shontz, & Coyne, 1980; Shekelle, et aI., 1981; Todarello et aI., 1994).

Prevalence of Psychiatric Diagnosis in Cancer Populations.

Estimations of the prevalence of emotional illness or the percentage of cancer patients
that meet the criteria for a psychiatric disorder range from no disorder (Roberts, Rossetti, Cone,
& Cavanaugh, 1992) to 50% (Craig & Abeloff, 1974). The most frequently cited investigation

(Derogatis, et aI., 1983) of 215 patients newly diagnosed with a variety of cancers found that
47% of patients met criteria for a psychiatric disorder. Of this 47%, 44% met Axis I (APA,
1994) diagnostic criteria and 12% met Axis II (AP A) criteria. Adjustment disorders had a
prevalence rate of 32%, major affective disorders 6%, organic disorders 4%, personality
disorders 3% and anxiety disorders 2%. Table 2 summarizes the studies that investigated
emotional illness patterns in cancer populations. For each identified study, it presents the size
of the sample, description of the population, the intervening variables controlled for, the method
of measurement, and results. The disparity in the results can be explained by the complexity of
and difficulty in controlling for the intervening variables: history, ethnic variability, variation in
sampling methods and sizes, lack of control groups, and the divergent methods of measurement.
There are at least three pervasive methodological problems with these studies. First, the
prevalence of emotional illness in cancer patients has been demonstrated to be related to a large
number of intervening variables. These include the type and location of the cancer (Holland,
1998; Lloyd, 1974), the stage of the disease (Akechi et aI., 2000; Tope et aI., 1993), physical
symptoms (Bredart et aI., 1999; Weisman & Worden, 1976-77), attitudinal factors (Lloyd;
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Weisman & Worder), social status (Cull et aI., 1995; Lloyd; Weisman), functional status
(Bredart)
et aI., 1999; Derogatis et aI., 1983), psychiatric history (Cull; Evans, Baldwin, & Garth, 1974;
Lloyd; Weisman & Worden), age (Bredart et aI.), substance abuse history (Weisman &
Worden), gender (Btedart et al.), intrusive thoughts (Baider & Denour, 1997), degree of selfmonitoring (Schwartz, Lerman, Miller, Daly & Masney, 1995), and type of treatment (Holmes,
1991; Lloyd). The nature of the relationship between the variables and distress is discussed in
greater detail below. None of the reviewed studies controls for all the potential intervening
variables. Such an investigation would require an enormous sample and a large test burden that
may be unacceptable in a population that fatigues easily.
Second, examination of Table 2 reveals that most conclusions about the prevalence of
emotional illness in cancer populations are drawn from convenience with no attempt to draw a
random sample (Bieliaukas & Garron, 1982; Craig & Abeloff, 1974; Farber, Weinerman &
Kupers, 1983; Kugaya et aI., 1998). Randomization is essential to control for the large number
of possible intervening variables. For example, in Farber and colleagues' study of216
histologically confirmed mixed cancer patients, the sequential sampling technique did not
control for history of emotional illness, stage of disease, length of time since diagnosis, or
gender. The result that 34.4% of sample patients are distressed according to SCL-90 (Derogatis
& Melisaratos, 1983) might be attributed to the patients' prior emotional status, to the recent

nature of diagnosis, or to the fact that this data was collected on the patient's first visit to a
cancer center or perhaps to gender or age. It is difficult to have confidence in the accuracy of
the reported results.
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Table 2
Prevalence ofAffective Disorders in Cancer Populations

n

Study

Akechi et aI., 2000

885

Method/Instrument

Subjects

Variables Controlled

.'

Incidence

Retrospective chart

Japanese cancer patients

12.9% ofthe sample

review for DSM-IV

with mixed diagnoses

met criteria for MDD.

(1999) criteria for Major

referred to the

535% of the depressed

Depressive Disorder

psychiatry division of

population had suicidal

(MDD)

the national cancer

ideation

hospitaL
Bredart et aI., 1999

220

Hospital Anxiety and

Italian patients with

Gender

34% exceeded the

Depression Scale

mixed diagnoses at the

Age

cutoff for psychiatric

(HADS; Zigmond &

European Institute of

symptoms

Snaith, 1983)

Oncology in Milan

16% met criteria for
anxiety or MDD

Holland and Mastrovito, 1980

62

Clinical Interview

Level of depression: at

42.0% were depressed

Beck Depression

least moderate

on interview

Inventory (BDI, Beck,
-

-------

----

36.0% had BDI scores
------

.... -

-

-

- -

- -
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n

Method/Instrument

Subjects

Variables Controlled

25

Incidence
I
I
•

Steer, & Garbin, 1988)
l30

Chochinov et a!., 1994

of14 or more

Schedule for Affective

Terminally ill

Disorders (SADS;

outpatients with mixed

depression

Endicott & Spitzer,

diagnoses

13.0 % moderate

' 9.2 % major

1978)

symptoms
26.1 % minor symptoms

30

Craig & Abeloff, 1974

SCL-90 (Derogatis &

Inpatients at a Baltimore

Mean scores were

Melisaratos, 1983).

hospital with mixed

equivalent to the normal

cancer diagnoses

population.

52% had depression
indexes between T=50
and T=60

43% elevated
somatization scores
113

Dean, 1987
------------

Present State

Breast Cancer patients

Gender

9.7% major depression
~-

---------

!
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n

Method/Instrument

Subjects

Variables Controlled

Examination (Dean,

26

Incidence

17.7% minor depression

1987)
'-:-

Derogatis et ai., 1983

215

Clinical Interview

Oncology inpatients at

47% had psychiatric

SCL-90 (Derogatis &

three collaborating

diagnoses

Melisaratos, 1983).

cancer centers

68% adjustment

Raskin Depression

disorder

Scale (RDS;

13% affective disorders

Schulterbrandt, Raskin

4% organic disorders

& Reatig, 1974).

3% personality

The Global Adjustment

disorders

to Illness Scale (GAl;

2% anxiety disorders

Morrow et ai., 1981)
Kamofsky Performance
Scale (KPS; Nickelson
et ai., 1976)
Evans et aI., 1986

83

-

Clinical Interview

----

Gynecological oncology

16.9% Adjustment

patients

Disorder with

-----

--
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27

Incidence

Depressed Mood
22.9% Major
Depressive Episode
Farber, Weinerman & Kuypers, 1985

216

SCL-90 (Derogatis &

Canadian outpatients

34.4% had one scale in

Melisaratos, 1983).

with mixed confirmed

addition to somatization

malignancies

elevated.
22.4% had two scale
elevations.
Depression, OCD and
Anxiety were the most
frequently elevated
scales

Ford, Lewis & Fallowfield, 1995

117

General Hospital

Cancer patients

Course of the illness

30% of sample had

Questionnaire-30

surveyed right after

Gender

psychiatric symptoms at

(GHQ-30; Goldberg,

hearing bad news

Age

time of news, 26% at

1992)

follow-up and 10% at 6

HADS (Zigmond &

months .
.

-----------

-
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Variables Controlled

28

Incidence

Snaith, 1983)
Kathol, Mutgi, Williams, Clamon & Noyes,

152

Structured Interview

1990

Oncology outpatients

?5%-38%, dependent

with mixed diagnoses

on the criteria
employed.

Morton et aI., 1984

Plumb & Holland, 1977

48

80

Geriatric Mental State

Geriatric

Age

39.6% depressed

Schedule (GMSS;

buccopharyngeal

Copeland et aI., 1976)

carcinoma patients

Semi Structured

Mixed diagnosis

45.0% at least moderate

Interview (CAPPS;

inpatients

depression

Endicott & Spitzer,
1972)
Roberts et aI." 1992

32

SCL-90 (Derogatis &

Gynecological oncology

Melisaratos, 1983).

survivors, no active

Time since diagnosis

100% SCL-90 scores
within normal limits

treatment
Roth et aI, 1998

97

HADS (Zigmond &
Snaith, 1983)

Gender

13% had psychiatric
symptoms, of the 13%:
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n
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Subjects

Variables Controlled

Incidence

32.6% were anxious,
and 15.2% were
depressed
Weddingtom. Segraves & Simon, 1986

33

SADS (Endicott &

Patients post amputation

24.2 % major

Spitzer, 1978)

with sarcoma

depression
15.2 % minor
depression
- - - -

29
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Third, the choice of measurement tools often reveals a general bias for short tools
(Costantini et aI., 1999; Farber, Weinerman & Kuypers, 1983; Ford et aI., 1995) developed in
hospital populations but not in cancer populations. Unfortunately, the overlap in symptoms,
etiology of cancer and its treatments, and the DSM-IV (1994) criteria for affective disorders
may lead to under diagnosis of affective problems in cancer populations (Lynch, 1995; Massie
& Holland, 1990) if tools do not allow for this overlap. A review of competing etiologies for

depressive symptomatology (Valente et aI, 1994) suggests that the physiologic symptoms of
depression, including: appetite change, weight change, insomnia, avolition and fatigue, can
often be accounted for by neurologic, metabolic, nutritional, pharmocologic or endocrine
changes resulting from cancer or its treatments. The same cancer pathology and treatments
often contribute to the development or exacerbation of affective disorders. One solution to this
problem (O'Boyle & Waldron, 1997; Whitlock & Siskind, 1979) is to isolate symptoms typical
of the affective disorder in the cancer population. For example; hopelessness, anhedonia, lack
of future focus, and suicidal ideation, rather than the classic somatic symptoms (fatigue,
anorexia and insomnia), might be the criteria for a depression diagnosis in this population.
Another solution involves a change in the diagnostic locus from taxonomy to experiential
criteria and from a threshold model to a continuum model (Holland, 1997).

The Prevalence of Distress in Cancer Populations.

Very little is known about the prevalence of distress in cancer populations. Perhaps little
can be known as distress varies greatly among individuals and is situational. The existing
estimates of distress prevalence often accompany reports of the psychometric properties of
instruments designed to measure distress, or an aspect of distress, in cancer populations. For
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example, using the Memorial Symptom Inventory (Portenoy, Thaler, Kornblith, McCarthyLepore, Friedlander-Klar, Kiyasu et aI., 1994) in a sample of 243 cancer patients, researchers
found that 60% of patients exceeded the cut -off score diagnostic of distress. Other researchers
using different instruments found the prevalence of distress in heterogeneous cancer populations
to be 54% (Pruitt et aI., 1991) and 72% (Holmes, 1991). Zabora and colleagues (1997) found
that the prevalence of distress in cancer outpatients was 38%, while in terminal patients it was
68%. Only one study used the Distress Thermometer (Roth et aI., 1998). In polling a sample
of 97 prostate cancer patients, they reported that 28.6% of the sample indorsed distress scores
exceeding the threshold for moderate symptoms.
A few studies also report the number of symptoms that contribute to the patient's
perception of distress. Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-KIaI',
Kiyasu and colleagues (1994) found mean number of symptoms contributing to the reported
distress to be 11. However, using the Symptom Checklist (Rhodes et aI., 2000) in 100 cancer
patients, great variability of the number of symptoms contributing to distress was reported. The
mean number of symptoms of28.7 +/- 13.4.
It appears one-third to almost two-thirds of cancer patients can be expected to
experience distress, that this experience is highly variable, and that the symptoms related to
distress also exhibit a wide range of variability. However, studies in large cohorts of cancer
patients aimed at analyzing the prevalence of distress are not reported in the literature. Increased
clarity in the estimates of prevalence of distress in cancer popUlations awaits the completion of
such research.

Factors Related to Psychiatric Symptoms/Distress in Cancer Populations.
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The risks of both psychiatric symptoms and distress are related to psychosocial and
demographic factors and to ineffective coping (Nezu et aI., 1998). The research on the risk
factors focuses on attributes of the highly distressed cancer population that differentiate it from
the less distressed population (Akechi et aI., 2000; Baider & DeNour, 1997; Bredart et aI., 1999;
Craig & Abeloff, 1974; Ganz et aI., 1993; Holmes, 1991; Passik et aI., 1995; Portenoy, Thaler,
Kornblith, McCarthy-Lepore, Friedlander-Kjlar, Coyle et aI., 1994; Roth et aI., 1998; Zabora et
aI., 1997). In contrast, the coping research focuses on divergent styles of perceiving the world
and on problem-solving styles that differentiate more symptomatic from less symptomatic
cancer populations (Behen & Rodrique, 1994; Burgess, Morris & Pettingale, 1988; Morrison,
Hislop, Mears & Kan, 1991; Nezu et aI., 1998; Taylor, Helgeson, Reed & Skokan, 1991).
The factors associated with psychiatric diagnosis and those associated with distress in
cancer populations may not be orthogonally related. In fact, cancer patients with symptoms that
meet diagnostic criteria for emotional illnesses would be expected to have more trouble coping
and solving problems associated with the disease (Nezu et aI., 1998). However, there is no
reason to believe that all factors that increase the risk for emotional illness in cancer populations
also automatically increase susceptibility to distress. Rather, Nezu and colleagues suggested
that an interactional model better accounts for patterns of cancer distress. In nonlinear
interactions, cancer-related problems increase risk of distress and psychosocial factors increase
or protect against this risk. For example, in one investigation of how social support influences
distress in the breast cancer population, Bloom and Speigel (1984) found a positive relationship
between social support from the patients' families and well being. Conversely, Roberts, Cox,
Shannon and Wells (1994) found a weak correlation between psychological distress and spousal
support in breast cancer patients. These authors concluded that a poor caliber of the
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pre-existing relationship and the presence of over-solicitous behaviors might increase, rather
than decrease, distress. Other studies found support to be helpful in come cases and deleterious
in others (Revenson, Wollman & Felton, 1983), or found no association (Cassileth et aI., 1985),
or negative association (Neuling and Winefield, 1988) between social support and distress in
various cancer populations.
Psychiatric symptoms that are typical of depression and anxiety have been found to be
related to several factors: declines in the individual's physical health or advancing stage of the
disease (Akechi et aI., 2000; Bredart et aI., 1999; Craig & Abeloff, 1974; Ganz et aI., 1993;
Holmes, 1991; Passik et aI., 1995; Portenoy, Thaler, Komblith, McCarthy-Lepore, FriedlanderKlar, Coyle et aI., 1994; Zabora et aI., 1997), age (Akechi; Bredart; Craig; Ganz; Roth), gender
(Bredart; Craig), and to psychosocial (Baider & DeNour, 1997; Craig; Ganz; Passik) and
cultural factors (Craig). In addition, the risk for distress increases as the number of problems
increase and coping strategies fail (Akechi; Ganz; Passik). Table 3 summarizes the studies
addressing risk factors related to psychiatric symptoms and distress in cancer populations.

Physical Symptoms and Prevalence of Psychiatric Diagnosis/Distress in Cancer Patients.

Troublesome physical symptoms, regardless of whether or not they signal disease
progression, have been shown to increase anxiety and depression (Akechi et aI., 2000; Bredart
et aI., 1999; Craig & Abeloff, 1974; Valente et aI., 1994). Researchers (Bredart) found that
cancer patients with fatigue, persistent nausea and vomiting, and pain were significantly more
likely than their symptom-free peers to display clinically-diagnosable depression or anxiety.
When declines in physical health begin to affect the individual's ability to be independent and to
exercise normal daily routines, further risk for emotional illness develops. One study of 885
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cancer patients (Akechi) found that when functional status decreased, the level of depression
and suicidality increased. Others (Bredart; Craig; Valente) found that the number of psychiatric
symptoms increased as patients became more disabled. Cancer patients that exceed the
threshold for moderate distress are much more likely to have physical problems severe enough
to alter their ability to'function in an independent way than their less distressed peers (Ganz et
aI., 1993).
Some researchers have attempted to describe the most common problem profiles that
contribute to distress in various cancer populations. For example, in a sample of 51 outpatients
(Holmes, 1991) in active treatment for a variety of cancers, the variation among distress scores
was accounted for by problems associated with the symptoms of fatigue, altered body image,
low mood, decreased concentration, loss of mobility, pain, and gastrointestinal symptoms.
Other studies (Passik et aI., 1995; Portenoy, Thaler, Kornblith, McCarthy-Lepore, FriedlanderKlar, Kiyasu et aI., 1994) concur that pain, fatigue, and gastrointestinal symptoms often
challenge coping resources as they are persistent problems that are often not well treated
(Holland et aI., 1998). These symptoms are consequently associated with increased risk of
distress, according to one well-constructed study (Portenoy). In this study of 243 patients with
ovarian, colon, prostate or breast cancer the researchers found that the mean number of physical
symptoms contributing to distress was 11. The symptoms were directly and highly correlated
with the distress level. The most frequently reported symptoms were fatigue, pain, insomnia,
worry, sadness, and irritability.
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Table 3

Risk Factors for Distress in Cancer Populations

Study

II

Subjects

Measures

Method

Outcome

Akechi et ai., 2000

885

Japanese patients with

Psychiatric

Retrospective chart

Psychiatric diagnosis:

Increased as

mixed cancer

interview using

review

Severity of depression

functional status

diagnoses referred to

DSM-IV(l994)

and suicidal ideation

decreased, with

the Psychiatry

criteria for Major

age of 60 or older

Division for

Depressive

and with later

Depression

Disorder (MDD)

stage of the

c

Factor

I

disease.

I

I

283

Baider & DeNour, 1997

Israeli stage I and II

Brief Symptom

Correlational

Psychiatric diagnosis:

Both BSI and lES

breast cancer patients

Inventory (BSI;

surveys

BSI score of 63 or

scores were

receiving outpatient

Derogatis, 1993)

administered on an

above psychiatrically

directly related to

unspecified

diagnostic

trauma history.

lES scores on a

Intrusive thoughts

follow-up treatment

-

147 with a trauma

Impact of Events

history and 106 with

Scale (rES;

outpatient visit

- - - _ . _ - --

- - - -
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Subjects

Measures

no trauma history

Horowitz, Wilmer

Method

Outcome

Factor

continuum

explained 30% of

& Alvarez, 1979)

the variance in BSI
scores.

c

Lack of education
also contributed
22% to the
variance in
Subjects with BSI
scores below the
cutoff
---

-- ---

-
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There is evidence (Zabora et aI., 1997) that in later stages of the disease the distress
profile increases due to problems with mobility, pain, and gastrointestinal dysfunction.
Imminent death is also associated with high distress symptom scores (Craig & Abeloff, 1974)
although not necessarily with psychiatric diagnoses (Zabora). In fact, distress may exhibit a
bimodal or trimodal relationship with the stage of the disease. Ford, Fallowfield and Lewis
(1994) studied 117 cancer patients who just received the news of an initial cancer diagnosis or a
recurrence of cancer. The sample was assessed three times over the course of the ensuing six
months. At the time of the first assessment 20% of the sample reported distress. At 3 months,
the time of the second assessment, 14% of the sample reported distress. By the end of6 months
only 9% of the sample remained distressed. This pattern suggests that distress may peak at
times when the patient's perception of the disease changes. In exploring the interaction between
time since diagnosis and distress, Derogatis et aI., (1979) found that patients in treatment for
more than 1 year were more depressed, hostile, and cognitively disturbed than patients who
were earlier in the disease process.

Age and Psychiatric Symptoms in Cancer Populations

The relationships between age and psychiatric symptomatology in a heterogeneous
cancer population are not as clear. A large retrospective study (Akechi et aI., 2000) of Japanese
cancer patients found that those who were more than 60 years old were more depressed and
more likely to have suicidal ideation than patients younger than 60. Other studies in American
cancer populations (Bredart, et aI., 1999, Craig & Abeloff, 1974) found that risk of distress
increased in the 59 to 65 years-old group and the less than 35 year old cohort in female
populations. Ganz and colleagues (1993) also found that older women with breast cancer are at
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more risk for distress and are more incapacitated by the disease than their younger peers. In
reviewing the distress patterns in a prostate cancer population, Roth and coworkers (1998)
explained the direct association between advancing age and distress in their population as the
effect of multiple losses. Their conjecture was that elderly cancer patients were more likely to
have experienced a recent loss of a spouse or siblings and, in many cases, these losses resulted
from cancer. However, one study of a cohort of243 patients (Portenoy, Thaler, Kornblith,
McCarthy-Lepore, Friedlander-Klar, Kiyasu et aI., 1994) found no relationship between age and
distress scores. The studies' measurement of divergent outcome criteria and cultural diversity
may account for some of the variation of the descriptions of the relationships found between age
and distress. Also, adult developmental variations are not well understood (Feldman, 2000) nor
is the interaction between the type of cancer and age (Holland, 1997).

The Effect of Gender on Riskfor Psychiatric Symptoms.

The interaction between risk for psychiatric diagnosis or distress and gender in cancer
populations is just beginning to be explored. It appears that both psychiatric symptoms and
distress may differ by gender (Bredart et aI., 1999; Faller, Bulzebruck, Drings & Lang, 1999;
Ford, Fallowfield & Lewis, 1994; Keller & Henrich, 1999). Recent studies are informative but
reach contradictory conclusions. In a sample of 103 lung cancer patients, Faller found that
women reported more symptoms of anxiety while men reported more symptoms of depression.
In interviewing a cross sectional sample of 246 German cancer patients with mixed diagnoses,
Keller and Heinrich reported that both genders described similar physical and psychological
problems. However, 54% of women reported high distress levels while only 28% of men
complained of high distress. Women reported more psychosomatic symptoms and found
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physical symptoms to be more troublesome than men did. Context appeared to contribute more
to distress among men than women. Ford and colleagues found that the pattern of anxiety and
depression differed by gender over time, as changes in the course of the disease occurred. Last,
Bredart and associates found that more women than men with cancer exceeded the score for
psychiatric symptomatology on the HADS (Zigmond & Snaith, 1983).

Impact of other Variables on Riskfor Distress Associated with Cancer

The literature is replete with discussions about the impact of psychosocial and
demographic variables on the risk for psychiatric symptomatology and distress in cancer
populations (Baider & DeN our, 1997; Bielauskas & Garron, 1982; Bredart et aI., 1999;
Costantini et aI., 1999; Craig & Abeloff, 1974; Dattore et aI., 1980; Derogatis, Abeloff &
Melisaratos, 1979; Everson et aI., 1996; Faller et aI., 1999; Farber, Weinerman & Kuypers,
1983; Keller & Henrich, 1999; Lloyd, 1979; Mahon & Casperson, 1995; Passik et aI., 1995;
Persky, Kempthorne-Rawson & Shekelle 1987; Schwartz, Lerman, Miller, Daly & Masny,
1995; Tope et aI., 1993). Some articles summarize clinical or observational experience and
draw a large number of conclusions about a plethora of variables ranging from the effect of the
loss of a primary relationship to the effect of financial problems (Bieliaukas; Lloyd). In terms
of psychiatric symptoms, Baider and DeNour reported that less educated subjects experienced
more emotional difficulties. Low socioeconomic status (Craig) also correlates directly with
affective difficulties in cancer populations. The risk of distress has been found to increase with
psychiatric history (Ganz et aI., 1993), inadequate social networks (Ganz et aI., 1993; Passik),
marital difficulties (Ganz), financial problems (Ganz), and sexual difficulties (Passik). Cultural
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biases also influence the distress profile in ways that are not well understood. The risk for
emotional symptoms in a Canadian cancer population was estimated to be 34.4% (Faller et al.,
1999), close to the incidence most usually reported in American populations. However, Hurny
and his co-researchers (1993) found significant differences between a German and an Italian
population both in the number of problems reported and the distress associated with the reported
problems. The Italian population scored higher than the German population on both measures.
This beginning work does little to add to our knowledge of the potential interaction among
factors and lacks the breadth necessary to draw any but the most preliminary conclusions.

The Role a/Coping Responses.

Studies of newly diagnosed cancer patients demonstrate that the most effective coping
responses, are "confronting" responses. These responses include: use of religion, adopting a
positive approach, changing perceptions in a way that seems beneficial, rehearsing emotions
anticipated in response to event and consequences, planning positive events and activities, and
exercising imaginative control over the outcome. They are associated with enhanced
psychological well being (Behen & Rodrique, 1994; Burgess, Morris & Pettingale., 1988;
Morrison, Hislop, Mears & Kan 1991; Taylor et al., 1991). Conversely, a study of patients with
advanced cancer (Felton, Revenson & Hinrichsen, 1984) found little relationship between
coping resources and psychological adjustment. This discrepancy may indicate a trend for
coping skills to diminish in effectiveness as physiologic compromise increases. Taylor and
colleagues also found that adaptive coping responses were dependent upon the stage of the
illness and the prognosis. For persons early in the illness, with a good prognosis, coping
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included reliance on others. For those with a poor prognosis, self-generated feelings of control
were most adaptive.

An awareness of the factors that increase vulnerability for distress will

help to identify at risk portions of the whole cancer population. Now let us turn to the
consideration of how best to measure distress both in the at risk and general cancer popUlations.

Distress Screening Tools

Psychometric Requirements.

The value of a screening instrument in both clinical and research applications is
determined by its psychometric properties and clinical utility. Two major psychometric
questions must be answered before researchers and clinicians can be confident that an
instrument acceptably measures the variable in question: (a) Is the screening-tool a reliable or
consistent measure ofthe property or attribute it claims to measure?; and (b) Is the tool a valid
measure, or to what degree does it really measure what it claims to measure? (Aiken, 1996;
Keppel, 1991; Nunnally & Bernstein, 1992)
The question addressing the instrument's reliability further focuses on the stability of the
results produced by the screening tool and the consistency of its items. Results are stable if the
measure produces the same outcome when given repeatedly to the same subject, ifthe measure
produces the same results regardless of the arrangement of items and if two or more raters using
the instrument to measure the variable in one particular subject arrive at the same results.
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Test-retest, parallel forms and inter-rater reliability analyses gauge the stability oftest results,
over time, within the arrangement of items and between two or more raters respectively (Aiken,
1996; Grant et aI., 1990; Nunnally & Bernstein, 1992).
As previously discussed, the distress screening instruments considered here are all
constructed in a self-report format. Inter-rater reliability is not a relevant parameter for the
evaluation of self-administered screening tools. Stability of scores is of interest if the attribute
measured changes little over time. For example a measurement of height is expected to have
excellent test-retest reliability. It is a somewhat irrelevant concept when the attribute being
measured is a trait whose expression is expected to change over time, thus producing unstable,
rather than stable, measurements. For example a measurement of weight in a growing infant
would be expected to have little or no test-retest reliability when measured over time. As
defined, distress is a trait-like variable and in the measurement of distress, test-retest reliability
analysis produces a spurious statistic of little use for evaluating distress assessment instruments
(Aiken, 1996; Grant et aI., 1990; Nunnally & Bernstein, 1992).
The second tenant of the tool's reliability examines the consistency of performance of a
group of individuals across the items in a measure. Responses on consistent items will be
highly correlated with each other. The more a measure is internally consistent, the more likely
that all of the items quantify the same concept. Internal consistency is reported as an alpha
coefficient and a value of. 70 or greater increases confidence that the instrument is measuring
just one concept. (Grant et aI., 1990) A good measure of distress would have an alpha
coefficient of. 70 or greater.
A second branch psychometric evaluation attempts to define the structure of components
that contribute to the formation of the concept being measured. This analysis examines the
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relative correlation among and between responses to the scale's items and proposes a solution to
account for the variance among the item scores in a group of individuals. The statistical
approach for this research is factor or cluster analysis. In accordance with previous research
(Coyle et aI., 1996; deHaes et aI., 1990; Hurny et aI., 1993; McCorkle & Young, 1978;
O'Boyle & Waldron', 1997; Peruselli, et aI., 1993; Rhodes et aI, 2000; Schag et aI., 1991; Schag
& Heinrich, 1990; Schipper et aI., 1984; Sollner et aI., 1998), a good measure of distress should

include factors related to physical problems, to emotional problems, to practical problems and to
interpersonal problems, or should display a four-cluster solution.
After the instrument's reliability is established, it is examined in an attempt to ascertain
that it is measuring what it claims to measure. There are three major types of validity: content,
construct and criterion. A tool's content validity refers to the extent to which the items
adequately sample the content area in question. It is usually either established by agreement of
a panel of experts in the field or through extensive literature review. When a panel of experts
establishes the appropriate content, a content validity index (CVI) may be reported. The closer
to 1.0 the CVI, the higher the agreement among the panel of experts (Grant et aI., 1990). The
process for identifying the content of the distress-screening tool should be published in a report
of an early trial of the tool.
Construct validity refers to the ability of a tool to perform according to theoretical
predictions. A tool that is sensitive to differences between groups and demonstrates those
differences in a predictable direction exhibits construct validity (Aiken, 1996; Grant et aI., 1990;
Nunnally & Bernstein, 1992). For example, distress scores should be higher in the cancer
population than in a "normal" population. Also patients with relatively few symptoms should
be less distressed than those with many symptoms. Since distress changes over the course of
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the cancer experience (Ford et aI., 1995), and is problematic at sub-clinical levels (Holland et
aI., 2000), an adequate distress measure should be sensitive to the current situation of the
patient.
Finally, criterion validity refers to a relationship between an instrument and an outside
indicator. There are two subtypes of criterion validity, concurrent and predictive. Concurrent
validity refers to the subject's performance on the instrument and on another indicator that
measures the same or a parallel concept, when the measures are administered at the same time.
If both indicators measure the same concept, the scores on the instruments should correlate
highly or display convergent validity. If the indicators measure on different concepts, the scores
on the instruments in question should produce low or moderate correlation or divergent validity.
(Aiken, 1996; Grant et aI., 1990; Nunnally & Bernstein, 1992). Distress tools might exhibit
convergent validity with other measures of distress and divergent validity with measurements of
quality of life, psychiatric symptoms or resiliency in cancer populations. By contrast, predictive
validity refers the correlation between sets of data collected at different times. One set of data
may be used to predict the scores on another measure. The most usual example of this is the use
of scholastic aptitude scores to predict college performance. Distress scores have been used to
predict morbidity (Fawsy, 1994; Holland, 1997; Lloyd, 1979; McDaniel et aI., 1995) and
mortality in cancer populations (Derogatis et aI., 1979; Faller et aI., 1999; Fawsy, 1994;
Morrison & Paffenbarger, 1981).
Additionally, a sufficient distress screening scale should meet criteria for clinical utility
constructed by researchers (Barg et aI., 1994; Finlay & Dunlop, 1994; Grant et aI., 1990). To
review, the criteria identified include: (a) the tool is specific for the cancer population; (b) it is
self-administered and easily interpreted; (c) it identifies the patient's risk for psychosocial
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problems; (d) it is short with little response burden; (e) it serves to triage patients to appropriate
services; and (f) it is capable of identifying cancer-related problems in multiple dimensions.
The review of the literature for instruments that measure distress in cancer populations
yielded six instruments in varying stages of development. In all six, distress is an emotional
reaction to unresolved problems associated with the cancer experience, rather than a psychiatric
symptom or a parameter of quality of life. They are the Rotterdam Symptom Checklist
(deHaes, van Knippenberg, & Neijt, 1990), the Modified Symptom Distress Scale (Holmes,
1991), the Adapted Symptom Distress Scale-2 (Rhodes et aI., 2000), the Memorial Symptom
Assessment Scale (Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Coyle,
1994), the Memorial Symptom Assessment Scale-Short Form (Chang, Hwang, Corpion &
Feuerman, 1997) and the Edmonton Assessment Scale (Bruera, Kuehn, Miller, Selmser, &
Macmillan, 1991). The scales are reviewed below.

Rotterdam Symptom Checklist (RSC).

The RSC (deHaes, vanKnippenberg & Neijt, 1990; see Appendix B) is a 38-item
checklist that measures distress related to cancer specific symptoms in three domains of
functioning. Patients are asked to report the degree that physical, psychological or functional
symptoms have bothered them over the past week. The administration time is approximately 15
minutes. Scores are reported on a 4-point Likert-type scale from "not at all" to "very much".
The scale was constructed by secondary analysis (deHaes et aI., 1990) of items from the Dutch
version of the Symptom Distress Scale (McCorkle & Young, 1978), the Hopkins Symptom
Checklist (Derogatis, Lipman, Rickels, Uhlenhuth & Covi, 1974) and a breast cancer distress
scale (deHaes et aI., 1996). Scale items were selected on the basis of factor loading in the initial
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sample, for their relevance to the diagnosis as judged by a panel of experts and according to the
distribution of answers in the validation study (deHaes, Pruyn & vanKnippenberg, 1983). The
scale produces subscale scores for physical and psychological distress and for overall activity
level. It also produces a single overall score that estimates the patient's quality oflife.
The RSC's items exhibited internal consistency in groups of heterogeneous Dutch
cancer patients who were treated with chemotherapy (deHaes et aI., 1983), in a large crosscultural sample of heterogeneous cancer patients treated with chemotherapy (Jones & Coleman,
1993), and in samples of newly diagnosed heterogeneous Dutch and Scottish cancer patients
(Soukop et aI., 1992). The Chronbach's Alpha (CA) for psychological symptoms ranged from
.85 to .94, while the statistic for physical symptoms ranged from .80 to .87, and the CA ranged
from .61 to .95 for activity level. Further, the overall quality of life score was related to all
subscales; for physical symptoms ~=.75 to .79, for psychological symptoms! =.56 to .65 and
for activity level! =.58 (deHaes et aI., 1996).
Factor analysis in the original sample (deHaes et aI., 1983) described a two-factor model
consisting of physical (37.5% ) and psychological symptoms (28%) of the variance. In other
samples (Jones & Coleman, 1993; Soukop et aI., 1992), factors related to fatigue and
gastrointestinal symptoms were identified dependent upon the time in the course of the disease
when the measurement was taken.
The scale's construct validity is relatively well established. The subscale scores for
physical distress were correlated with the physical distress items on the Medical Outcome
Study-36 (Ware & Sherbourne, 1992), while the psychological distress subscale correlated well
with the HADS (Zigmond & Snaith, 1983) and the Adjustment to Illness Scale (Morrow et aI.,
1981) in a sample of 216 cancer patients who exhibited evidence of psychopathology (Watson
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et aI., 1992). Paci (1992) also found the psychological subscale to be related to the scores on
the State-Trait Anxiety Scale (r =.70; Spielberg, 1985) in a sample of 278 heterogeneous cancer
patients undergoing active treatment.
The checklist has been shown to be a sensitive measure distress in a number of clinical
trials in cancer populations. Souhami and colleagues (1997) used the RSC to report differences
in distress between subjects treated with oral and intravenous palliation for lung cancer. They
found that intravenous chemotherapy in this sample of terminally ill patients was associated
with the same or less distress as oral chemotherapy and with prolonged survival. Other authors
(Macbeth et aI., 1996) found that the psychological distress subscales of the RSC discriminated
between groups receiving low-dose radiotherapy and those receiving high-dose radiotherapy in
a sample of 250 small cell lung cancer patients. Patients receiving the high-dose radiotherapy
were less distressed than patients receiving low dose therapy. In additional studies the RSC
defined abnormal distress levels in a group of breast cancer patients treated with Cisplatinum
(deHaes, 1996), and differentiated between cancer populations and disease-free popUlations
(Watson et aI., 1992)

Adapted Symptom Distress Scale-2 (ASDS-2).

The ASDS-2 (Rhodes et aI., 2000; see Appendix E) is a 31-item self-report inventory of
distress associated with 14 common cancer symptoms. Each item is rated on a 5-point Likert
scale with 0 being no occurrence of the symptom and 4 being a symptom that causes the most
distress. It is an adaptation of the SDS (McCorkle & Young, 1978) designed to more accurately
represent the spectrum of common cancer symptoms and to clarify certain confusing questions.
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The symptoms included are: nausea, vomiting, pain, eating, sleep, fatigue, bowel elimination,
breathing, coughing, lacrimination, changes in body temperature, appearance and restlessness.
The instrument yields a total score, a score for symptom distress and six sub-scale scores. The
sub-scales include gasterointestional symptoms, pain/discomfort, respiratory symptoms,
concentration and appearance.
The scale was developed by deleting items from the Adapted Distress Scale-l (Rhodes,
Watson & Johnson, 1984) that exhibited only moderate reliability and adding three items:
lacrimation, changes in body temperature and restlessness, based on clinical observation and
reports of cancer patients (Rhodes et aI., 2000).
The tool exhibited good internal consistency in a sample of 354 adults (82
medical-surgical patients, 175 oncology inpatients and 95 healthy adults). The CA was 0.91 for
total symptom experience, 0.76 for total distress and 0.90 for total occurrence. Sub-scale
reliabilities ranged from ~ = 0.64 to ~ = 0.83. (Rhodes et aI., 2000).
Other reported psychometric parameters include the scale's test-retest reliability and
content validity. The test-retest reliability with a 2-week interval in 28 hospitalized
medical surgical patients was ~ = 0.92 (Q < .001; Rhodes). Content validity was supported via
review of the literature and through cancer patient's reports about symptoms (Rhodes et aI.,
2000).
The scale discriminated between the well group and the oncology patients (2 < .001), but
not between the well group and the medical-surgical patients for total symptom experience. It
discriminated among all three groups for symptom occurrence, but did not discriminate between
the oncology and medical surgical group in terms of symptom distress scores. (Rhodes et aI.,
2000) There are no reports of the scale's construct validity.
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Memorial Symptom Assessment Scale (MSAS).

The MSAS (Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Kiyasu et
aI, 1994; see Appendix F) is a 33-item Likert scale instrument that measures the severity,
frequency and distreSs associated with symptoms experienced by cancer patients. The list of
symptoms was compiled through a review of the cancer literature and modified following an
initial trial of the scale in a sample of 297 cancer patients. The internal consistency was high for
the prevalence of symptoms and the psychological state sub-scales (a = .88 and .83) and for the
pain sub-scales (a =.87). It was moderate for gastrointestinal distress (a =.75) and low for
symptoms with less prevalence (a =.58).
In the same study (Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar,
Kiyasu et aI, 1994) factor analysis yielded a principle component that reflected the overall
symptomatology and accounted for 24% of the variance among scores and two major factors:
psychological symptoms and physical symptoms. Each of these factors can be sub-divided into
two smaller factors. Content validity estimates focused on the role of the dimensions of
severity, frequency and distress for each symptom in order to evaluate the potential of
multidimensional assessment of each symptom. Mean severity and frequency scores were
correlated (r = .80) across symptoms as were mean severity and distress scores (r = .70).
Conversely, the correlation between mean frequency and distress scores was low. Further
canonical correlation analysis suggested that distress was the most informative dimension in the
multidimensional approach.
The tool differentiated between cancer inpatients and outpatients (Chang, Hwang &
Kasimis, 1995; Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Coyle et aI,
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1994; Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Kiyasu et aI, 1994). In
all studies inpatients reported significantly higher MSMS total scores than outpatients. It also
discriminated among patients without cancer, those with local disease and those with distant
metastatic disease (Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Kiyasu).
Those with distant metastatic disease reported the highest scores. Patients with local disease
reported moderate scores, and cancer-free subjects reported low scores.
In one population, highly significant correlations (2 < .001) with scores on the Memorial
Pain Assessment Card (MPAC; Fishman, Pasternak, Wallenstein, Houde, Holland & Foley,
1987), the Revised Rand Mental Health Inventory (RAND; Veit & Ware, 1983), the Functional
Living Index Cancer (FLIC; Schipper et aI., 1984), the Symptom Distress Scale (SDS;
McCorkle & Young, 1978), and the Karnofsky Performance Scale (KPS; Nickelson et aI., 1976)
were found (Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Kiyasu et aI,
1994). These correlations were for the total MSAS scores, the single dimensions of severity,
frequency and distress and for major symptom groups averaged across dimension. The scale's
predictive validity has not been reported.
The MSAS (Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Kiyasu et
aI, 1994) was used by researchers to measure quality of life in advanced breast cancer patients
receiving chemotherapy by researchers (Seidman et ai., 1995). The researchers found that
tumor responses to chemotherapy were associated with changes on MSAS scores. It was used
to assess distress in clinical cancer trials (Ingham, Seidman, Yao, Lepore & Portenoy, 1996).
The scale differentiated the distress levels in ovarian cancer patients with a KPS (Nickelson et
aI., 1976) score of 80 or less from those with a KPS (Nickelson) score of 90 or more (Kornblith
et aI., 1995). It was used to quantify the effect of hydrocortisone treatment in 21 hormone-
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refractory prostate cancer patients on quality oflife (Curley, Liebertz, Portenoy, Kelly & Scher,
1994). Curley and colleagues found an inverse relationship between Prostate Specific Antigen
(PSA) levels and MSAS scores. The MSAS has also been used in additional research
applications (DuPen et ai., 1999; Hann, Jacobsen, Martin, Kronish, Azzarello & Fields 1997;
Harrison et ai., 1997; Payne, Mathias, Pasta, Wanke, Williams & Mahmoud 1999) to quantify
distress and quality of life in cancer populations.

Memorial Symptom Assessment Scale- Short Form (MSAS-SF).

The MSAS-SF (Chang et ai., 1997) is an abbreviated version of the MSAS that
measures symptoms only in the distress and frequency dimensions. Chang and his colleagues
trialed the tool in a sample of 75 mixed diagnoses cancer patients. They reported that all of the
MSAS summary scales were reliable on the MSAS-SF

(~

= .94 for the total symptom index, ~ =

.73 for the physical symptom sub-scale and ~ = .67 for the psychological symptom sub-scale).
Criterion concurrent validity for the general score and physical and emotional well-being
sub-scales with the Functional Assessment Cancer Therapy (FACT; Cella et ai., 1993 ) was
established to be 2 < .001. No predictive validity or current usage of this scale is reported.

Edmonton Symptom Assessment Scale (ESAS).

The ESAS (Bruera et al., 1991; See Appendix G) consists of nine 100-mm visual
analogue scales representing symptoms or activities important to cancer patients in the terminal
phase of the illness. These parameters include numerous symptoms: pain, inactivity, nausea,
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depression, anxiety, drowsiness, appetite, shortness of breath and sensation of well being. It
was designed for use in a palliative care population. Symptoms are either self-reported or
assessed by professional staff twice daily and recorded on a graph that compares results across
21 days. Scores are repOlied for each symptom and a global performance rating is assigned.
Summing the individual scores produces a global distress score. Scores are directly related to
symptom severity.
A panel of palliative care experts (Bruera et al., 1991) identified the parameters included
on the scale. Tool's psychometric properties are just beginning to be reported. A small sample
of 22 mixed diagnosis palliative care cancer patients (Philip, Smith, Craft & Lickiss, 1998)
produced scores on the Rotterdam Symptom Checklist (deHaes et al., 1983) that were highly
correlated with their scores on the ESAS supporting the ESAS's concurrent validity. A later
prospective study in 240 palliative care cancer patients (Chang, Hwang & Feuerman, 2000)
found that the ESAS distress score correlated most closely with the physical symptom subscales
of the Functional Assessment of Cancer Therapy (FACT; Cella et al., 1993) and MSAS and with
the KPS (Nickelson et al., 1976)
The individual items and summary scores exhibited good internal consistency and
correlated well with like items on the MSAS (Portenoy, Thaler, Kornblith, McCarthy-Lepore,
Friedlander-Klar, Kiyasu et aI, 1994) and FACT (Cella et al., 1993; Chang et al., 2000). Test
re-test reliability was better at 2 days but the correlation was smaller at the end of a week,
suggesting that the scale does not measure a steady trait. The distress score also tends to reflect
the patient's physical well being.
The ESAS (Bruera et aI., 1991) scores discriminated between a group of patients who
died and a group who were discharged from a palliative care unit (Rees, Hardy, Ling, Broadley
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& A'Hern, 1998). Scores for both groups worsened over the 5 days of data collection, and there

were no significant differences between the groups on the overall distress scores. However, the
group that was discharged experienced a significant improvement in pain scores, while the
group that died showed a significant deterioration in activity, drowsiness and appetite prior to
death. It has also been used to audit the effectiveness of symptom control in a sample of
palliative care patients (Dudgeon, Hados & Clinch, 1999) and to describe relationships among
medication, demographic and symptom profiles in a palliative care population (Jenkins, Schultz,
Hanson & Bruera, 2000).

Summary.

All of the self report measures of distress reviewed have acceptable internal consistency,
and most have respectable psychometric evidence of their validity as measures of distress in
cancer populations. In addition, they meet at least four of the seven clinical criteria (Barg et aI.,
1994; Finlay & Dunlop, 1994; Grant et aI., 1990) previously described as desirable for a
screening tool. All the measures are specific for cancer populations; they are self-administered;
they identify specific psychosocial problems; and they measure multiple dimensions. However,
the need for a general screening tool for distress in the large general cancer population raises
several challenges that cannot be addressed by the existing instruments.
First, recall that cancer is not one but rather some 200 different diseases (Holland et aI.,
1998). Therefore, symptoms in the general cancer population are highly variable. It is likely
that some distressing low incidence symptoms will not be addressed by a scale produced
through review of the literature for common symptoms. For example, patients with tumors
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surrounding or impinging on the optic nerve may experience distressing visual losses. This
source of distress will be missed by all of the reviewed scales, while the DT (Holland et al.,
2000) provides for a direct analogue measure of distress itself and the option to respond to an
"other" category if, or when, symptoms do not apply.
Second, variability of symptoms that contribute to distress is evident in the divergence
of factor structures discovered when a tool is administered to different cancer populations and in
different cultures. Some authors (Cooley, 2000; Friedman, Webb, Richards & PIon, 1999;
Sturgeon et aI., 1998) have proposed that distress scales for specific types of cancer might solve
this problem. This solution may be appropriate in research settings or in arenas that deal
exclusively with specific cancer diagnoses. It does little to address the need for a distressscreening instrument to be used in large heterogeneous cancer populations. The DT's (Holland
et al., 2000) approach of screening for general distress and abandoning the notion of quantifying
distress associated with problems identified through professional consensus may offer a viable
alternative for general cancer populations.
The response burden may also be problematic in cancer populations with high
fatigability (Derogatis, 1993). In recognition of this issue, attempts have been made to shorten
the screening tools. For example, Chang and colleagues (1997) shortened the MSAS to reduce
response burden. Even this shortened form calls for judgment of individual symptoms in
several dimensions and requires five to ten minutes for completion. It lacks depth in its reported
validity profile and there has been little use in research. The DT (Holland et aI., 2000) requires
60 seconds or less for administration, thus poses little threat of response burden.
All of the tools reviewed previously require the calculation of sub-scale and aggregate
scores. Although these calculations may be simple compared to the scoring of psychological
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tests, scoring requires staff training and time. It is possible that insufficient man-hours for
scoring and follow up has been a barrier to distress screening. Additionally, staff resistance to
work burden may deter efforts to screen all patients. The DT (Holland et aI., 2000) produces an
easily interpretable score that requires no preliminary calculation.
Last, only the DT scores lend themselves to a triage system as described in the NCCN
practice guidelines (Holland, et aI., 2000). In this system, referrals to appropriate health care
providers are made according to the level of distress reported. Referrals generated in response
to the range of the patient's distress score vary from requests for peer support to psychiatric
intervention.
Since the DT (Holland et aI., 2000) has not been subject to psychometric analysis it
seems prudent to proceed with an evaluation of its performance in a large heterogeneous cancer
population.
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Hypotheses

The Distress Thermometer (Holland et aI., 2000) is designed to measure distress as
defined by the NCCN in general cancer populations. Recall that the NCCN (2000) definition of
distress is:
An unpleasant emotional experience of a psychological (cognitive, behavioral,
emotional), social, and/or spiritual nature that may interfere with the ability to cope
effectively with cancer and its treatment. Distress extends along a continuum, ranging
from common normal feelings of vulnerability, sadness, and fears to problems that can
become disabling, such as depression, anxiety, panic, social isolation, and spiritual
crisis. (p. DIS-2)
The foUowing four hypotheses were tested in this research.

Hypothesis One.

The scores on for the sample will be reliable

(~

::: .7), and a factor analysis using the

items of the DT (Holland et aI., 2000) representing multiple problems that are associated with
distress in the cancer population will yield four homogenous subgroups of items. Problems
routinely reported to produce distress in cancer populations are physical problems (Finlay &
Dunlop, 1994; Ganz et aI., 1993; Q'Boyle & Waldron, 1997; Rhodes et aI., 2000; Schag &
Heinrich, 1990; Sollner et aI., 1998), emotional problems (Finlay; Ganz; Q'Boyle; Rhodes;
Schag; SoUner), practical problems (Finley; Ganz; McCorkle & Young, 1978; Roth et aI.,
1998; Schag) and interpersonal problems (Finlay; Ganz; Q'Boyle; Rhodes; Schag; SoUner).
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.5) and will be directly and

significantly correlated (2::: .01) with the total distress score as measured on the analogue
thermometer.

Hypothesis Two./

The NCCN Distress Thermometer total score obtained in a general cancer patient
population will display a positive relationship with the Rotterdam Symptom Checklist total
distress score (deHaes et aI., 1990). The RSC (deHaes) is a measure of distress associated with
38 common cancer symptoms in three domains of the four domains addressed by the DT
(Holland). It does not address distress associated with interpersonal problems. As with most
measures of distress in cancer populations (Finlay & Dunlop, 1994; Ganz et aI., 1993; O'Boyle
& Waldron, 1997; Rhodes et aI., 2000; Schag & Heinrich, 1990; Sollner et aI., 1998) there is no

spiritual domain included on the RSC (deHaes). The RSC (deHaes) total score sums the
distress profile, as does the score on the Distress Thermometer, and has been found to be a valid
measurement of distress in cancer populations (Watson et aI., 1992). High correlation between
the scores obtained in the study sample on the two instruments suggests that the DT displays
concurrent validity.
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Hypothesis Three.

The Distress Thermometer (Holland et aI., 2000) total score will display a positive
relationship with the FLIC total score (Schipper et aI., 1984). The FLIC is a valid measure of
functional status in cancer populations (Schipper).
Hypothesis Four.

Total scores on the NCCN Distress Thermometer (Holland et aI., 2000) will be highly
correlated with high Brief Symptom Inventory (BSI; Derogatis, 1993) global severity index
(GSI) scores. The BSI is a valid measurement of psychiatric symptoms in cancer populations
(Derogatis, 1982) and the global severity score best indicates the amount of distress associated
with the symptoms reported by respondents to the BSI.
Additionally, highly distressed members of the sample (scoring 7-10) are likely to report
high GSI scores and undistressed (scoring 0-3) respondents are apt to report a low GSI score, so
a significant correlation (2 .:s .01) between the high and low distress scores and the GSI will be
found. It is likely that some patients who meet the criterion for a diagnosis of distress (scoring
4-7 on the DT) in the sample will report low BSI scores, others will report moderate scores and
still others high scores. Thus a lack of correlation between BSI (Derogatis) scores and moderate
DT total scores will demonstrate divergent validity.
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Methods

Overview a/the Research Design

In this study a craSs sectional psychometric design in a sample of heterogeneous cancer
patients was analyzed. This research tested some of the properties of the NCCN Distress
Thermometer (Holland et aI., 2000) in the sample's responses. A principal components factor
analysis with varimax rotation was performed to identify the factors underlying total distress
scores in this population. Convergent validity was tested by comparing the DT (Holland) total
score with the total scores from both the RSC (deHaes, van Knippenberg & Neijt, 1990), a
well-established measure of distress in cancer populations, and the FLIC (Schipper et aI., 1984),
a measure of cancer patients' quality of life. To test divergent validity, the total, low, moderate
and high total scores of the DT (Holland) were compared with global severity index(GSI) scores
of the BSI, a score that quantifies distress associated with psychiatric symptoms (Derogatis,
1993).

Measures and Apparatus

The NCCN Distress Thermometer (DT; Holland et al., 2000; see Appendix A).

An analogue scale anchored at one end by a zero rating indicating no distress, and at the
other by a rating of 10 or severe distress. Scores are reported as a single line drawn through an
integer on the thermometer and either yes or no responses to 33 problems commonly
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experienced by cancer patients; distress associated with the problems endorsed contributes to
the total distress recorded as a summary score on the analogue scale. A panel of expert
psycho-oncology practitioners from 18 comprehensive cancer centers developed the scale in
1998. It received a class "2A consensus" from the group (NCCN, 2000). The category 2A
consensus means thaUhere is uniform NCCN consensus, based on low-level evidence,
including clinical experience, that the recommendation is appropriate. It was designed to be an
inexpensive, easily administered tool for broad screening in cancer popUlations and to lead to
appropriate triage for the purpose of distress treatment. The administration time is less than a
minute. Its scores demonstrated a 74.4% concordance with the scores on the HADS (Zigmond
& Snaith, 1983) in a sample of 121 prostate cancer patients (Roth et al.,1998). Its remaining

psychometric properties have not been reported. As the tool is early in development, there are
no reports of studies employing the DT (Holland) to date.

The Brief Symptom Inventory. (BS1; Derogatis, 1993,' see Appendix D).

The BSI is a 53-item, shortened version of the SCL-90 (Derogatis & Melisaratos, 1983).
It is designed to measure psychological symptomatology on a 5-point Likert scale of 0, (not at
all) to 4, (extremely). The test yields three global indices: the Global Severity Index (GSI), the
Positive Symptom Total (PST) and the Positive Symptom Distress Index (PSDI) and subscores
on nine symptom dimensions. The test takes eight to ten minutes to administer. Its internal
consistency, test-retest reliability, convergent and divergent validity, equivalence to the SCL-90
and factor structure have been tested and found to be acceptable (Derogatis, 1982). Stefanek,
Derogatis and Shaw (1987) found the incidence of psychological distress in an outpatient
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population of 126 cancer patients to be 23.8% using the BSI (Derogatis). This demonstrates its
sensitivity for measurement of psychological distress. in cancer populations. Edwards,
DiClemente and Samuels (1985) differentiated the psychological profiles of long-term cancer
survivors from those of short-term survivors based on BSI (Derogatis) scores. Two studies
(Schain, Wellisch, Pasnau & Landsverk, 1983; Wellisch, Gritz, Schain, Wang & Siau, 1991)
evaluated distress profiles in breast cancer populations with the BSI and found differences
among study groups. Finally, Shover, Fife and Gershenson (1989) employed the BSI
(Derogatis) to evaluate treatment effects in a sample of cervical cancer patients.

The Rotterdam Symptom Checklist. (RSl; deHaes et aI., 1990; see Appendix B)

A 38-item distress checklist that measures three domains of functioning. Patients are
asked to report the degree that physical, psychological or functional symptoms have bothered
them during the past week. Scores are reported on a 4-point Likert type scale from 0 (not at all)
to 3 (very much). It is internally consistent and exhibits concurrent validity with the HADS
(Zigmond & Snaith, 1983) and the Adjustment to Illness Scale (AIS; Morrow et aI., 1981) in a
cancer population that exhibited evidence of psychopathology (Watson et aI., 1992). It has been
shown to be a sensitive measure of distress in a number of clinical trials in cancer populations
(Macbeth et aI., 1996; Souhami et aI., 1997; Stephens et aI, 1997) (See previous section entitled
Review of Distress Tools for further discussion).
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The Functional Living Index-Cancer. (FLIC; Schipper et al., 1984,' see Appendix C).

The index is a 22-item cancer-specific quality of life questionnaire. Items are self-rated
on a linear analogue scale that measures variables in five domains: physical well being,
emotional state, sociability, family situation and nausea. The scale is easy to administer and
takes less than 10 minutes to complete. The FLIC (Schipper) was found to be a reliable
measure in a population of 530 cancer patients (Morrow et aI., 1992). The factor structure was
consistent across three different cancer populations (Schipper et aI., 1984). Concurrent
validation studies (Schipper) with the Karnofsky Performance Index (Nickelson et aI., 1976),
the Beck Depression Scale (Beck, Steer, & Garbin, 1988), the Spielberg State-Trait Anxiety
Questionnaire (Spielberg, 1985), the scaled version of The General Health Questionnaire
(Goldberg, 1992) and the McGill/Melzack Pain Index found that the PLIC (Schipper) accounted
for a high percentage of the sample variation by principle components. The questionnaire's
scores in another sample were independent of measures of symptoms and anxiety (Morrow,
Lindke & Black, 1992). It has been used as a measure of quality of life in a wide variety of
clinical studies in cancer populations.
The Statistical Package for Social Sciences (SPSS version 10.0,2000) was used for the
analysis of all data.
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Procedures

Testing Materials.

Testing materials were assembled in packets that included: (a) an instruction sheet (see
Appendix H); (b) a demographic sheet (see Appendix I); (c) the DT (Holland et ai., 1998); (d)
the BSI (Derogatis, 1993); (e) the RSC (deHaes et ai., 1990); (f) the PLIC (Schipper et ai.,
1984); and (g) an 8 liz x 11 inch manila envelope. Tests were in identical order in each packet.
Each item was labeled with a unique five-digit code. Packet codes began at 20001 and ended
with 20250. Every Tuesday during the data collection period, the principal investigator
distributed test packets and a supply of consent letters to the areas involved in the project.

Inclusion of Study Participants and Informed Consent.

To be included in the study, subjects were at least 18 years old, and able to do all of the
following: see well enough to read the items, speak and read English, hold a writing implement
and be aware of their cancer diagnosis. Demented, delirious or psychotic patients were
excluded from the study. In outpatient areas, a researcher (either the principal investigator or
one of nine registered nurses who had been trained to obtain consent and collect data)
approached patients when they registered for treatment. The researcher checked the birth date
on the patient's identification plate to confirm that the subject was at least 18 years old. The
researcher observed the patient's registration process. The requirement that the patient speaks
English was met if the patient completed registration independently, without the use of an
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interpreter. If the patient responded appropriately to the researchers' conversational questions,
the criterion that he/she is of sound mind was met. The researchers also observed the patients
handle a writing implement during registration to rule out motor impairment. The researchers
then asked all patients meeting the study entrance criteria for consent to participate in the
research project.

"

In inpatient areas, the researchers queried the primary nurse to assure that the patient met
the study criteria. Further, the patient's mental status and ability to handle a writing implement
were assessed directly by the researcher at the time of data collection to assure the absence of
transitory problems with cognition.
Those patients giving consent then completed two copies of the informed consent form
(See Appendix J), returned one copy to the staff and retained the second copy for their records.
The researcher witnessed the consent, and answered any questions. If the researcher was not the
principal investigator, and he/she could not resolve questions relative to the consent, the
principal investigator was contacted. This happened only twice during the study period, in both
cases the patients required reassurance that they would not be contacted in the future to provide
more data. Completed consent letters were then placed in the consent letter file folder in a
secured research file box. In order to conceal the patients' identities and protect privacy, signed
consent letters were stored separately from the completed test materials

Completion a/Tests by Participants.

After the consent was obtained, the patient was given an envelope containing the
research materials. The patient was asked to complete all portions of the testing materials, per
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the instructions, and to return the completed forms in the sealed envelope to the researcher. The
researcher remained in the clinical area to answer questions and assist the patients as necessary,
but did not read materials for the subjects. Completed test packets, along with consent letters
were retrieved by the principal investigator every Tuesday and data aggregated in SPSS version
10.0 (2000).

Participants and Demographic Data

Subjects Lost to the Study.

Of the 250 subjects who signed informed consent letters and took research packets, four
subjects in radiation oncology left the area without returning the data and seven more (two in
radiation oncology and five in the MPA) did not complete all requested tests. Because
participation was blinded, nothing is known about those subjects who did not complete the
testing.

Participants' Demographic Data.

A sample of 239 adults being treated for cancer in either outpatient or inpatient areas in
a large community teaching hospital provided complete data. The complete demographic
profile of the sample is described in Table 4. Of the sample 210 were outpatients, 19 were
inpatients and 10 did not indicate their status. There were 146 females and 93 males. Eighty
one percent of the subjects ranged in age from 44 years old to 79 years old.
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The sample reported a variety of cancer diagnoses. The most frequently reported type of cancer
was female breast cancer (11.2%), followed by prostate (5.7%), lung (4.1 %), colon/rectal
(3.9%), ovarian (3.4%), lymphoma (1.8%), pancreatic (0.7%), stomach and kidney (each 0.2%)
cancers. Six and eight-tenths percent of the sample reported other types of cancer diagnoses.
Most subjects were being treated for a primary occurrence of the disease and were within a year
of diagnosis. Most reported low level of, or no, pain associated with the diagnosis, and were
treated with at least two types of medications in addition to the primary cancer treatment. The
cancer treatment for the majority of the sample was chemotherapy (15.1 %). Radiation therapy
alone (9.1 %) or combinations of treatments (l 0.1 %) were typical in the rest of the sample.
Of the sample, 81 % was educated at the high school level or more, and 25% held
graduate or technical degrees. The majority of the respondents earned between $10,000 per
year and $50,000 per year and was disabled, unemployed by choice or retired at the time of the
study. The average subject resided with his/her significant other. The subjects were
predominately Caucasian.

Validation Distress Thermometer
Table 4

Demographic Profile
Percent of

Percent of
Variable

t'

Number

Sample

Outpatient
Not Reported

Number

Sample

Extent of Cancer

Admission Status
Inpatient

Variable

19

7.9

Primary

210

87.8

Occurrence

123

51.5

10

4.1

Reccurrence

33

13.8

Local Disease

19

7.9

Metastatic Disease

38

15.9

4

1.7

73

30.5

109

45.6

53

22.2

4

1.7

20

8.4

72

30.1

45

18.8

Not Reported

-Sex
Female
Male

146

6l.1

93

38.9
Time Since the Current

Age

Diagnosis

18-30

6

1.0

31-43

20

3.3

3 months or less

44-55

56

9.1

3 months to 1 year

56-67

68

11.1

More than I year

68-79

71

11.6

Not Reported

80-91

18

2.9
Education

Type of Cancer
Breast

69

28.9

Some High School

Prostate

35

14.6

High School

Lung

25

10.5

Diploma

Colon/Rectal

24

10.0

Some College

75

Validation Distress Thermometer
Percent of

Percent of
Number

Variable

Variable

Sample

Number

Sample

Ovarian

21

8.8

College Degree

38

15.9

Lymphoma

11

4.6

Graduate Degree

29

12.1

Pancreatic

4

1.7

Trade/technical

Hodgkin's

2

0.8

30

12.6

Stomach

I

0.4

5

2.1

Kidney

1

0.4

42

17.6

4

1.7

t'

Other
Not Reported

School
Not Reported

Living Arrangement

Yearly Income

Lives Alone

Less than $10,000

16

6.7

$10,001-25,000

60

25.1

Lives with Significant

$25,001-50,000

57

23.8

Other

$50,001-75,000

40

16.7

Lives with Significant

$75,001-120,000

34

14.2

Other and

More than $120,000

11

4.6

Dependent Children

Not Reported

21

8.8

Lives with Parents

44

18.4

134

56.1

28

11.7

3

1.3

4

1.7

20

8.4

6

2.5

Lives with Significant
Other and Parents
Other
Not Reported

76
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Percent of

Percent of
Number

Variable

4

1.7

93

38.9

Radiation Therapy

56

23.4

Hormonal Therapy

2

0.8

Surgery + Chemotherapy

4

1.7

Surgery
"

8.4

Chemotherapy +

20
7.9

Surgery + Chemotherapy

Sample

3

1.3

Nausea

13

5.4

Fatigue

.J

1.3

Vitamins

19

7.9

Hormones

8

3.3

24

10.0

104

43.5

More than Three

14

5.8

None

47

19.7

4

1.7

Pain

Other

Radiation Therapy

Number

Current Medications

Current Treatment

Chemotherapy

Variable

Sample

More than One

Not Reported

19

..,

9.6

+ Radiation Therapy

7.5
Other

23

Not Reported

18
Current Level of Pain

Ethnicity

210

87.8

0

125

52.3

African-American

5

2.1

1

22

9.2

Hispanic

4

1.7

2

21

8.8

Other

2

0.8

3

18

7.5

18

7.5

4

13

5.4

5

6

2.5

6

7

2.9

7

6

2.5

Caucasian

Not Reported

77
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3

1.3

9

I

0.4

17

7.1

Not Reported
Employment
40 Hours a Week or
More

39

16.3

21-39 Hours a Week

10

4.2

20 Hours a Week or Less

15

6.3

Unemployed by Choice

54

22.6

Disabled

44

18.4

Retired

53

22.2

Not Reported

24

10.0

78
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Distress Profile.

The participants' reports of distress varied widely. Analysis revealed an even
distribution of scores, ranging from zero (no distress) to 10 (the worst imaginable distress). The
most frequently reported level of distress was zero (5.2%). The next most frequently reported
distress score was 5.0 (4.1%). Table 5 summarizes the distress profile of the sample. The
average level of distress in the sample was 4.268, with a standard deviation of 3.178. The cutoff
score of 5, signifying moderate or clinically significant distress, was met or exceeded by 37.7%
of the sample.
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Table 5
Distress Profile (n=239)
Analogue Distress

]i'reguellcy ofthe

Score'
,

*"

,

Percent of the Sample

Score
$

Cumulative;

,$"

O~O

32

0.2

2

13.4

13.4
14.2
14.6

0.3

05

Percentage

,

6.7

21.3

0.4

21.8

0.4

22.2

14

5.9

28.0

2

"0.8·.

28.9

OA

29.3

16

29.7
34.3

11

0.4

34.7

0.4·

35.1

18

7.5

42.7

2

0.8.

43.5

2

0.8

44.4
44.8
49.8

12

4.5

2

0.2

50.2

0.2

50.6

0.8

51.5
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Score

~

m

Score' ,

¥"

~"t§umulative

Percent oHhe Sample,

004.

5.0

81
~

'

Percentage '.'

51.9

25

10,$

62.3

5

2.1

64.4
64.9
69.0

10

69.5

4

1.7

71.1

0.4

71.5
78.7

17

79.1
79.5
4

81.2

12

86.2

0.4

86.6

0.4

87.0

7

2,9

90.0

10

432

94.1

5

2.1

96.2

9

3.8

100.0

Validation Distress Thermometer

82

Frequency ofSymptoms.

The total number of problems reported had a significant relationship with the analogue
distress score (! = .53, £ < .0001). The most frequently reported problem associated with
distress in this sample was fatigue (51.6%) and the least frequently reported problems were
trouble with child care and loss of faith (each 2.1 %). Table 6 presents a summary of the
problems reported by the sample in order of descending frequency. The mean number of
problems associated with distress ascribed to by the sample was 5.38, with a standard deviation
of 4.97. The range was zero to 27. The total number of problems had a significant relationship
to the total analogue distress score (! = .53, £ < .0001).
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VaHable

Number Positive

Percent

Fatigue

130

5l.6

Worry

99

39.3

Problems with Sleep

90

35.7

75

2S>.8

Depression

74

29.4

Sadtless

63 -

·25.0

Constipation/Diarrhea ..

63

25.0

55

21.8

53

2l.0

51.

·20.2

46

18.3

Problem~D~alingwith Partner

c

.

Changes i~ Bowel Functioning

. 43
Functioning
Nausea

42

16.7

Problems with Eating

41

16.3

Problems with Work

37

15.2

Problems Getting Around

34

13.5

Problems Dealing with

32

12.7

Changes in Skin

32

12.7

Problems Breathing

31

12.3

,

'_ ... ,

.:2::..'. .':"

..-_.

Children
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·Percent
"} I,J

Problemswithlndigestton'
Problems Relating to God

25

9.9

Problems\"ith Hciusing

24

9.5

changes in Urinary

24

9.5

,Problems with Insurance

23

9.1

Nasal Congestion

23

Functioning

23
Probl~ms with tra~sportation'·

19
18

Problems with Sore Mouth

13

5.2

'Fever

10

4;0

9

3.6

5

2.1

5

2.1

.

,

Other Problems

Problems with Child

C~~e
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Results

The reliability of the responses to DT items was evaluated using Chronbach's alpha. An
alpha of at least .7 was required for confidence in the scale's reliability. Although Nunnally
(1978) originally recommended that the alpha coefficient be .8 or .9 for basic research, modern
researchers (Clark & Watson, 1998, pp.230) accept that an alpha coefficient of.6 or .7 is a good
or adequate indicator of internal consistency.
A factor solution was derived using Pearson-r correlation matrices of the 33 items on the
Distress Thermometer for the sample (n = 239). A principal components factor analysis with
varimax rotation was performed. Results were checked against the scree to verify data fit. The
reliability of the factor solution was checked in two ways. First, a Pearson's product moment
correlation matrix of each factor with the total distress score was constructed with a correlation
of 2 < .01 considered significant. Second, each factor's reliability was confirmed using
Chronbach's alpha. Because it is expected that lesser factors may identify a logical component
of the concept, while not demonstrating the level of relationship among the items that initial
factors demonstrate, a less rigorous standard of ~ = .5 was used for confidence in the factor's
reliability.
The correlations among the DT (Holland et aI., 2000) total score, reported as an integer
ranging from zero to ten, the total score of the RSC (deHaes et aI., 1990), reported as an integer
ranging from zero to four, the total score of the FLIC (Schipper et aI., 1983), reported as an
integer ranging from zero to seven, and the OSI of the BSI (Derogatis, 1993) reported as an
integer from zero to four were analyzed in a correlation matrix using the Pearson's product
moment comparisons. Although the scores on the Distress Thermometer (Holland et aI., 2000)
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are nonparametric data, authors (Aiken, 1996; Nunnally & Bernstein, 1992) suggest that
Pearson's! is sufficiently robust to be used in non-interval applications. Correlations with a
probability of2 < .01 were considered significant.
The correlations between global severity index scores of the BSI (Derogatis, 1993) and
the low medium and htgh total scores of the DT (Holland et aI., 2000) were further analyzed in
three correlation matrixes. DT (Holland) scores of three and less were considered low, those
between four and six were considered moderate, and those of more than seven were considered
high. As before, the BSI (Derogatis) scores were reported as integers ranging from zero to
four. The matrixes were analyzed for the significance of the relationship between the variables
using Pearson's product moment correlations. Correlations with a probability of 2 < .01 were
again considered significant.

Reliability and Factor Structure.

The internal consistency of the analogue distress thermometer scores was high

(~=

.86).

Factor analyses were performed using the default options of the SPSS program version 10
(2000). An II-factor solution was derived (See Table 8). Table 9 lists the individual items on
the Distress Thermometer (Holland et aI., 2000) to the left, displays factor loadings of 0.4 or
greater for each item and provides a summary of the item's communality. A comparison with
the scree confirmed that an II-factor solution was a suitable model for the data. The
reliabilities of the factors ranged from ~= .74 (factor 1) to ~ = - .08 (factor 11). The reliability
analysis is summarized in Table 7, and discussed below. Each factor with the exception of
factor 11 was significantly correlated with the total distress score. Factor loadings were
analyzed and factors named by a panel of three experts.
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Table 7

Reliability of the Factor Solution
Factor Name

Chronbach's Alpha

Negative Emotion

.7438

Interpersonal/Social Problems

.7379

Physical Symptoms/GI

.6685

Treatment Side Effects

.5507

Problems with Activities of Daily Living

.6045

Physical symptoms/Neurologic

.5274

Physical symptoms/Infection/Excretory

.5915

Dryness/Epithelial Cell Changes

.4730
**.1118

Nausea

.4002

Other
Childcare

**-.0832

* *Factor exhibits insufficient reliability for interpretation

Factor Analysis.
Overall 63.3% of the sample variance is accounted for by the II-factor solution. (See
Table 8) Examination of the factor loadings produced an interpretable factor pattern.
Twenty-four of the 33 items had factor loadings of 0.4 or greater on only one factor. Nine items
were not associated with a single factor as they had loadings of 0.4 or more on two or more
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factors. These nine items included problems with work/school, bowel changes, problems with
eating, insurance, transportation, mouth sores and difficulties with sleep, fatigue and sex.
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Table 8
Factor Structure: Analysis

Factor

Eigenvalue

%of

Cumulative

Variance

%of
Variance

Negative Emotion

6.186

18.744

18.744

Interpersonal/Social Problems

2.349

7.117

25.861

5.647

31.508

Physical Symptoms/GI
Treatment Side Effects

1.654

5.012

36.520

Problems with Activities of Daily Living

1.559

4.723

41.243

Physical symptomslNeurologic

1.503

4.554

45.797

Physical symptoms/Infection/Excretory

1.328

4.025

49.821

Dryness/Epithelial Cell Changes

1.235

3.742

53.564

Nausea

1.132

3.430

56.994

Other

1.059

3.210

60.204

Childcare

1.035

3.137

63.341
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Table 9
Items Loading on Each Factor

Negative

Social!

Physical

Treatment

Activities of

Physical

Physical

Dryness/

Emotion

Inter-

Symptoms/

Side Effects

Daily

Symptom!

Symptoms

Epithelial

Personal

Pain/GI

Living

Neuro

Infection!

Changes

Nausea

Other

Childcare

Community

Excretory

Item
Sadness

0.8

0.629

Worry

0.7

0.581

Nervous

0.7

0.658

Depressed

0.6

0.652
0.8

0.710

Housing

0.8

0.724

Dealing

0.5

0.581

Relating to
God

children
Work

0.5

Dealing

0.4

Partner

0.4

0.578
0.572

I

Negative

Social!

Physical

Treatment

Activities of

Physical

Physical

Dryness/

Emotion

Inter-

Symptoms/

Side Effects

Daily

Symptom/

Symptoms

Epithelial

Personal

Pain/GI

Living

Neuro

Infection/

Changes

Nausea

Other

Childcare

Community

Excretory
Constipat-

0.7

0.545

0.6

0.562

ion/
Diarrhea
IndigestIon
Bowel

0.6

0.4

0.599

Changes
I

Pain

0.5

Eating

0.4

Insurance

0.4

0.570
i

0.5

0.588
-0.5

0.627

0.7

0.675

Swelling

0.7

0.596

Mouth

0.6

Loss of
Faith

0.4

0.728

Sores
Getting
Around

0.7

0.652

Negative

Social!

Physical

Treatment

Activities of

Physical

Physical

Dryness/

Emotion

lnter-

Symptoms/

Side Effects

Daily

Symptom/

Symptoms

Epithelial

Personal

Pain/GI

Living

Neuro

Infection!

Changes

Nausea

Other

Childcare

Com-

I

munity

Excretory
0.5

Bathing

0.532

Dressing
-0.4

Breathing
0.5

Transport

-0.5

0.703
0.650
I
I

0.7

Tingling

0.679

Hand/foot

!

0.5

Sleep

0.4

0.638
0.8

Childcare
0.8

Other
0.7

Nausea
Fatigue

I

0.4

0.4

Changes in

0.740
0.656
0.681
0.558

0.7

0.666

0.6

0.616

Urination
Fever
Skin

0.8

0.663

0.6

0.651

Dry/Itchy
Nose Dry/
-

-

-

L------. .... _~ ____ . _ ' - - - - - - -

---

Negative

Social/

Physical

Treatment

Activities of

Physical

Physical

Dryness/

Emotion

Inter-

Symptoms/

Side Effects

Daily

Symptom/

Symptoms

Epithelial

Personal

Pain/GI

Living

Neuro

Infection/

Changes

Nausea

Other

Childcare

Community

Excretory
Congested
Problems

!

0.4

0.4

0.4

0.642

with Sex
-'-----

-

'---------

"------

--

-
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Four items loaded most heavily on the Factor 1: sadness, worry, depression, and
nervousness. Items concerning trouble dealing with one's partner and fatigue, both
symptomatic of affective dysfunction (DSM-IV, 2000) were also associated with this factor.
These items appear to refer to negative mood or affective issues. The factor accounted for
18.75% of the commonivariance and was called "Negative Emotions". It exhibited robust
reliability

(~=

.74).

Five items loaded on Factor 2. They were problems relating to God, problems with
housing, difficulties relating to partner, difficulties relating to children and problems with work.
Sexual issues were also associated with this factor. If housing issues were related to the
inability to exercise the interpersonal skill set necessary to find and keep a job, as they generally
are (Hall, 1999), the common factor in these items is failure of relationships. The factor
accounted for 7.1 % of the sample variance and was named "Interpersonal/Social Problems"; the
factor was highly reliable

(~=

.74).

The third factor accounts for 5.65% of the common variance and was composed of four
items that describe gastrointestinal symptoms and pain. The items were constipation or
diarrhea, indigestion, changes in bowel patterns, and pain. Problems with eating and with sex
also loaded on this factor. These gastrointestinal problems are common side effects of many
chemotherapy agents (Valley & Balmer, 1999), and of opiod pain medications (BaummID,
1999). The factor was referred to as "Physical Symptoms/GIIPain". It exhibited good
reliability in this sample

(~

= .67).

The three items that loaded on the fourth factor were loss of faith, feeling swollen and
mouth sores. The factor accounted for 5.01 % of the variance. These problems are common
effects of both radiation therapy (Laszlo et aI., 2001) and certain adjunctive medications and
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chemotherapy (Chabner, 1982). The factor was named "Treatment Side Effects". Its reliability
coefficient was acceptable

(~

= .55).

Factor 5 accounted for 4.72% of the common variance. Three items trouble with
bathing and dressing, problems getting around and difficulties with transportation loaded on this
factor. Trouble with ea'ting was also associated with the factor. The problems described were
inability to accomplish usual activities necessary for daily living and deterioration in quality of
life that often results from cancer and its treatments (Schag et al., 1991). The factor was dubbed
"Activities of Daily Living (ADL)" and performed well in terms ofreliability

(~=

.60).

The items loading on the sixth factor were trouble with tingling in the hands or feet and
difficulties with fatigue and sleeping. The factor accounted for 4.55% of the variance. The
problems are associated with neuropathies and neurological issues (Rubin, Kimmel & Cascino,
1998; Wang & Schroder, 1998) and the factor was called "Physical ProblemslNeurologic". It
achieved an alpha level of .53.
Factor 7 was composed of changes in urination and bowel function, sexual problems and
fevers. It accounts for 4.02% of the sample variance and was called "Physical
Symptoms/Infection/Excretory Problems". Confidence in its reliability was adequate, a = .59.
th

Items that loaded on the 8 factor were problems with dry/itchy skin and a
dry/congested nose. Mouth sores were also associated with this factor. It accounted for 3.74%
of the common variance. These problems all result from the destruction of rapidly mUltiplying
epithelial tissues, and the factor was named "Dryness/Epithelial Changes". The alpha
coefficient for Factor 8 was a = .47.
Factor 9 was inversely correlated with insurance and transportation and directly
correlated with nausea and accounted for 3.43% of the common variance. The reliability
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coefficient for this item failed to meet the threshold for confidence a

=

96

.11. No interpretation of

this factor was possible.
Other problems, trouble sleeping and problems with work loaded on Factor 10. Factor
10 accounted for 3.21 % of the variance. It was not possible to ascertain what respondents
c'

meant by "other problems", and the factor's reliability fails to meet the desired thresholp (a =
0.40). Like Factor 9, Factor 10 was uninterpretable.
Factor 11 accounted for 3.13 % of the variance. It represented only five cases and was
not significantly related to the total distress score (! = .531,2 < .025). The reliability coefficient
was likewise unacceptable

(~ = -

.08). Probably due to the small number of respondents

reporting child-care issues, this factor was not sufficiently reliable for confidence in its
interpretation.

Convergent Validity.

The total DT (Holland et al., 2000) scores were directly correlated with the Global
Severity Index (GSI) of the BSI (Derogatis, 1993) (! = .496,2- < .0001), the total score of the
RSC (deHaes, vanKnippenberg & Neijt, 1990) (!:,.= .505, 2-< .0001), and the total score of the
FLIC (Schipper et al., 1984) (!:,. = .641, 2-< .0001).

Sensitivity.

Low DT (Holland et al., 2000) scores (0-3) displayed an inverse relationship (r = -.445,
2-< .0001) with BSI GSI (Derogatis, 1993) scores, moderate DT scores (4-6) demonstrated no
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relationship (! = - .078,2 = 0.232) with BSI GSI scores, and high DT scores (7-10) a
significantly positive relationship (! = .399, 2-< .0001) with BSI GSI scores.

Discussion

Cancer, its symptoms and the side effects of its treatments cause biopsychosocial
distress. As cancer survivorship and chronicity increases (ACS, 2001), interest in the
identification and treatment of distress in the medical community also increases (Holland et ai.,
2000). Researchers (Bruera et ai., 1991; Chang et al., 1997; deHaes et al., 1990; Holmes, 1991;
Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Coyle et ai., 1994; Rhodes et
al., 2000) developed useful paper and pencil distress self-assessments in the 1980s. The time
required administering and scoring these tests made them undesirable for general screening in
large cancer populations. Within the limitations of this study, The NCCN Distress
Thermometer (DT, Holland et al., 2000), a brief, easily administered measure, appears to be a
conceptually sound, sensitive, reasonably internally consistent measure for distress screening
that performs in a valid manner.
The participants in this study were both similar tpo and different than the normative
national population. In its Cancer Facts and Figures (2001), the American Cancer Society
reported that 80% of cancers are diagnosed in middle age and the participants in this study are
most typically middle aged, so the age of the sample is typical for cancer patients in America.
The distribution of cancer diagnoses in the sample also mirrors current reports of the
distribution of specific cancers in the American population (ACS, 2001) except that cases of
Hodgkin's lymphoma are underrepresented in this sample. It is not clear why Hodgkin's
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Disease is underrepresented as the cancer center where the study was conducted treats this
illness. The symptoms of, and side effects of treatments for, Hodgkin's Disease include fatigue,
difficulty breathing and burns to the skin (Holland et al., 1998). These problems may be less
prevalent in the sample than expected. A factor that captures a like symptom profile might have
been identified in a §ample that included a normative number of patients with Hodgkin's
Disease.
The sample is unlike the national cancer population in at least two ways. First, the
overall gender distribution in the cancer population in the United States last year was reported to
be 51% male and 49% female (ACS, 2001). The sample in this study is predominately female.
The presence of regional gynecologic oncology and breast health centers at the site of data
collection account for this disparity between the gender profile of the sample and of the cancer
population as a whole. Women typically report more distress than men, especially distress
associated with pain (Bredart et al., 1999; Zigmond & Snaith, 1983). Therefore, it is possible
that the feminine nature of the study sample inflated the mean measure of distress and the
number of problems reported. The lack of non-Caucasian representation in the study sample is
attributable to the geographic location of the cancer center in a largely Caucasian suburb in
Pennsylvania. A recent health survey of the same area found that the non-Caucasian population
was 4% (Behavioral Health Risks of Lehigh Valley Adults, 1998), so the study sample
represents the local popUlation. Distress descriptions have also been shown to vary with
ethnicity (Faller et al., 1999; Hurny et al., 1993), although the differences between Caucasian
and non-Caucasian distress descriptions have not been studied.
Other issues of note are that there are few participants who are less than 30 years of age
included in the sample and that the majority of the participants had a localized cancer that was
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diagnosed in the last year, as opposed to chronic metastatic disease. The duration and severity
of the disease have been reported to be directly related to the severity of distress and the number
of cancer related problems reported (Akechi et aI., 2000; Bredart et aI., 1999; Tope et aI., 1993).
Patients with localized disease, relatively early in cancer treatment, are expected to have fewer
and less severe problerlls on average than those with metastatic disease in treatment for
prolonged periods oftime. This observation again points to the premise the levels of distress
and numbers of problems reported herein may underestimate those levels in the general
population.
The data support the premise (Holland et aI., 2000) that distress is a highly variable
phenomenon that results from failure to cope with a highly variable number of problems.
Similar variability was found by Holmes (1991) using the Symptom Distress Scale (McCorkle
& Young, 1978) in samples of radiation therapy and chemotherapy patients. The Mean distress

scores reported were 710.4 -+ 152.8 and 746.5 -+ 150.6 respectively. Likewise in Portenoy,
Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Coyle and colleagues' (1994) study of
the properties of Memorial Symptom Assessment Scale in an outpatient cancer population, the
mean number of symptoms reported was 9.7 with a variability of

±6.0.

High variability, both

in terms of standard deviations from the total distress mean and the number of problems
identified by subjects, is expected given the dynamic nature of cancer and its treatments, and the
transience, and complexity of associated symptoms. Disparities in total number of symptoms
may be related to the nature of the sample. For example Porteny's sample was predominately
inpatient colon/rectal cancer patients, while the sample in this study was predominately
outpatient breast cancer patients. The mean level of distress and numbers of numbers problems
associated with that mean are predictably higher in inpatients that typically have either more
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advanced disease or more debuilitating treatments, than for outpatients who are typically less
fragile. The relatively low level of distress and conservative numbers of problems found in this
sample may further be explained by observing that it does not include patients who are being
treated with physically incapacitating interventions like stem call transplants and abolition
interventions for leukemia. Regardless of the differences in patterns of central tendency, the
finding of large variability of both the level of distress, and the number of problems associated
with it, holds across differing samples and measurement devices.
The prevalence of clinically significant distress, or DT analogue scores of five or more
(37% of the sample), reported by the sample mirrors the prevalence of psychiatric symptoms in
cancer popUlations found in other some studies (Bredart et aI., 1999; Ford, Lewis & Fallowfield,
1995). A previously conducted study (Roth et aI., 1998) suggests that two-thirds of those
identified as significantly distressed through screening with the DT (Holland et aI., 2000) would
subsequently be diagnosed with affective or other psychiatric disorders at a second level
assessment. Although, second level assessment was not done in this study, 86% or 207 of the
239 respondents, reported some distress, 38% or 91, of the respondents' distress scores were
less than five, the cutoff score for significant distress. This finding has two implications. First,
all reported distress may be significant from a quality of life point of view and should be
evaluated through follow-up assessment. Second, more than 38% of this sample reported
subsyndromal distress that would certainly be missed using tests for psychiatric symptoms.
Interventions aimed at preventing emotional decompensation are most effective in these
distressed, but not emotionally ill, patients.
The internal consistency of the thermometer (Chronbach's Alpha (CA)= 0.87) in this
sample is equivalent to the reliability of other longer distress measures. For example, the CA
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for symptom distress using the Adapted Symptom Distress Scale-2 (Rhodes et aI., 2000) in a
sample of 175 oncology patients was 0.76. It was 0.88 for the Memorial Symptom Assessment
Scale (Portenoy, Thaler, Komblith, McCarthy-Lepore, Friedlander-Klar, Kiyasu et aI, 1994) in a
sample of 297 cancer patients. In this study, there is reasonable confidence that the DT
(Holland et aI., 2000) measures distress as its primary concept.
Eight reliable factors were identified. These factors fall into the same general domains
of emotional, interpersonal, physical, and practical problems as other measures of distress
(Bruera et aI., 1991; Chang et aI., 1997; deHaes et aI., 1990; Holmes, 1991; Portenoy, Thaler,
Komblith, McCarthy-Lepore, Friedlander-Klar, Coyle et aI., 1994; Rhodes et aI., 2000). Table
10 compares the factor structures of the five distress scales previously reviewed with the factor
structure of the DT in this sample population.
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Table 10

Comparison of Factor Structure Across Distress Measures

FLIC

EMOT

SOC

ADL

PHY 1

X

X

X

X

X

X

X

X

ASDS-2*
RSC

X

MSAS**

X

X

MSAS-SF

X

X

DT

X

X

X

X

PHY2

PHY3

PHY4

PHY5

X

X

X

X

X

X

X

X

X

Emot = Negative Emotions
Soc

=

Socialiinterpersonal Problems

ADL = Problems with Activities of Daily Living
Phy 1 = One dimension of physical symptoms
Phy 2 = Second dimension of physical symptoms
Phy 3 = Third dimension of physical symptoms
Phy 4 = Fourth dimension of physical symptoms
Phy 5 = Fifth dimension of physical symptoms

*ASDS-2: GI problems, pain/discomfort, respiratory problems, fatigue/restlessness,
concentration, *body image
** MSAS high and low frequency physical symptoms
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All of the scales have at least two major sub-scales, emotional and physical
symptomatology. Some scales do not have interpersonal items while others omit changes in
ability to manage activities of daily living (practical problems). Early work (McCorkle &
Young, 1978) demonstrated that a valid measurement of global distress requires only a
unidimensional meAsurement of a small group of prevalent psychological and physical
symptoms. So, distress measurement may be valid without interpersonal and practical
subscales, and the major disparity among factors identified in each distress measure that
remains is the number and composition of physical symptom subscales derived.
The difference among physical symptom subscales found in distress measurement tools
results both from differing experts' opinions about common physical symptoms found in the
general cancer population and the nature of the validation samples. Cancer can affect every
organ system and every human physiologic activity (Holland, 1997). Consequently, the list of
possible physical symptoms in a general cancer population can never be complete. This point is
easily illustrated. Many hematological cancers produce petechiae, or rash-like clusters of small
blood filled lesions, on the skin (Patrick, Woods, Craven, Rokosky, & Bruno, 1986, p.262);
none of the previously reviewed symptom checklists include problems with rashes. Also,
women experiencing premature menopause common in many chemotherapy treatments often
experience cold sweats. None of the reviewed symptom checklists offer "cold sweats" as a
potential response. The symptom list is potentially endless. Table 11 compares the symptoms
on five scales previously reviewed with those included in the DT (Holland et al., 2000). The
DT is one of two instruments that included an "other" symptoms category. Although only 9 of
the 243 subjects in this sample responded in the affirmative to the "other" category, the
response set was identified as a sub-scale of the instrument, Factor 10. The inclusion of the
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'other" category on the DT screening tool allows for a limitless list of problems that are not
specified on the checklist to be reported. The nature of these problems can be detailed in an
interview and appropriate clinical follow-up can occur.
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Table 11
Comparison of Physical Symptoms Across Distress Measures

DT
Other

X

Pain

X

FLIC

RSC

MSAS

ASDS-2

X
X

X

X

X

X

X

X

Stomachache
No Appetite

X

Nausea

X

X

Fatigue

X

X

X

X

Sleep

X

X

X

X

X

X

Coughing

X

Breathing

X

X

Mouth Sores

X

X

Eating

X

Indigestion

X

X

Constipation

X

X

X

X

Diarrhea

X

X

X

X

Bowel Changes

X

Urinary Problems

X

X

X
X

Sweats
Fevers

X

Dry Skin

X

X

Itchy Skin

X

X
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Dry Nose

FLIC

RSC

MSAS

X

X

Swallowing

X
/i

X

X

Shivering

X

Tingling Hands/Feet

X

Edema

X

Sexual Dysfunction

X

X

X
X

X

Sore Muscles

X

X

Vomiting

X

X

Dizziness

X

X

Weight Loss

X

Hair Loss

X

Burning Eyes

X

Bloated

ASDS-2

X

Dry Mouth

Congested Nose
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X

X

The first two factors underlying the construct of distress in the DT (Holland et ai., 2000)
reported by study respondents, negative emotion and interpersonal problems account for 25% of
the response variance. These factors are also predominate sub-scales in longer distress
measures (Bruera et aI., 1991; Chang et aI., 1997; deHaes et aI., 1990; Portenoy, Thaler,
Kornblith, McCarthy-Lepore, Friedlander-Klar, Coyle, 1994) confirming the role of
psychological issues in cancer distress. In this sample, the items loading on both factors were
exceptionally consistent. The items that compose Factor 1, sadness, worry, nervousness, and
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depression are all common labels for and fatigue, and marital dysfunction symptomatic of
affective difficulty (DSM IV, 1994). In Factor 2, trouble dealing with partner, and children
clearly signify interpersonal problems. Problems relating to God also loaded onto Factor 2. If
God is conceptualized as an anthropomorphic being, the interface between God and human
being becomes a relationship between mortal being and superhuman being. As with any
human-to-human relationship, interpersonal problems in the human-to-God relationship exit.
Anger, lack of trust in, and confusion about the relational rules occur in times of crises or
profound change (Bowen, 1978). The remaining two items in the sub-scale, trouble with work
and housing, are also associated with interpersonal difficulties. Inability to negotiate
relationships has be found to be associated with to, or is co-existent with, difficulty in obtaining
or maintaining employment (Hall, 1999). Under employment leads to and maintains difficulties
with housing. It appears that there may be two major expressions of affective distress in this
population: one experienced as ego dystonic or mood destabilizing symptoms and the other
experienced as disruption in relational systems.
Changes in functional status or ability to conduct activities of daily living result from the
increasing fatigue and general debilitation that is pandemic in cancer populations (Patrick et aI.,
1986). This sub-scale is conceptually consistent with the concept of distress. Its inclusion on
the DT (Holland et aI., 2000) makes it a more inclusive measure than some other less
parsimonious measures (Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar,
Coyle, 1994). It appears that while debilitation is related to distress, the debilitated population
in this sample is not the same as the emotionally upset population. A faction of the population
was debilitated and not emotionally destabilized. This finding disagrees with the work that
finds that emotional symptomatology increases as physical functioning decreases (Bredart et aI.,
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1999; Craig & Abeloff, 1974; Valente et al., 1994), but agrees with studies that find that the
level of distress is influenced by both emotional and physical problems (Passik et al., 1995;
Portenoy, Thaler, Kornblith, McCarthy-Lepore, Friedlander-Klar, Kiyasu et al., 1994). The
variables of emotional dysfunction and disability appear to be orthogonal subscales of distress
in this sample. A line!r relationship between functional symptoms and emotional symptoms
might have emerged if the study sample included a balanced number of inpatients who are
likely to be more physically disabled than outpatients and those considered terminal by medical
standards. Terminal patients usually are no longer in active treatment (although they may
receive interventions for symptom management). This group of patients is the most severely
functionally disabled. A relationship between declining functional status and increasing distress
may be found in terminally ill patients but not in outpatients in active treatment.
The DT (Holland et al., 2000) appears to describe the characteristics of a variety of
physical symptoms in this sample. Of these symptoms, there is growing evidence that those
associated with Factor 3; - pain, constipation or diarrhea (one item on the DT), bowel changes,
and trouble with eating - constitute a sub-scale of physical problems that transcend the
particular cancer diagnosis. The PainiGI symptoms factor found in this study equivalent to the
"high prevalence physical symptoms factor" of the MSAS (Portenoy, Thaler, Kornblith,
McCarthy-Lepore, Friedlander-Klar, Kiyasu et al., 1994), the FUC's Factor 5 (Morrow, Lindke
& Black, 1992) and the ASDFS's Factors 1 and 2 (Rhodes et al., 2000). Portenoyand

associates conclude that this factor has two subgroups, one related to pain and its treatment and
the other to gastrointestinal symptoms. They may have reached this conclusion because of the
large number of colon/rectal cancer patients in their sample. It is also plausible that this factor
identifies symptoms that result primarily from pain and its treatments. The most usual treatment
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for cancer pain involves a combination of nonsteriodal anti-inflammatory and opiate narcotics
(Baumann, 1999). Both classes of drugs have gastrointestinal side effects. The most notable
are the constipation and bowel problems that are persistent with the use of opiates (Baumann).
Due to slowed peristalsis, constipation is also associated with anorexia and indigestion; thus,
difficulty eating also';occurs. (Problems with eating and indigestion also load on this factor).
Pain is often comorbid with cancer progression and intensification of treatment. The longer the
course of the cancer treatment and the bigger the demand for ongoing health care, the more
likely that insurance coverage will become problematic. Therefore, the correlation between
insurance problems and pain, found in Factor 3, may be a secondary effect of chronicity. Of
this study's sample population, 33% reported problems with pain. Participants reported that
pain was second only to fatigue among distressing physical symptoms. Likewise, Factor 3
accounted for more of the sample variance than any other group of physical symptoms. This
finding concurs with the large body of literature that suggests that pain is a primary determinant
of cancer distress (Koopman, Hermanson, Diamond, Angell, & Spiegel, 1998; McClement,
Woodgate, & Degner, 1997; Payne et aI., 1998; Turk et aI., 1998; Zimmerman, Story, GastonJohansson, & Rowles, 1999) and suggests that a pain sub-scale has been identified among the
factors in this and other studies.
The remaining factors, Physical SymptomslNeurologic, Fever/Excretory Symptoms and
Dryness/Epithelial changes are similar to the group of low prevalence physical symptoms that
compose sub-scale three of the MSAS (Portenoy, Thaler, Kornblith, McCarthy-Lepore,
Friedlander-Klar, Kiyasu et aI, 1994). Heterogeneous samples can be expected to obscure
disease specific differences in symptom clusters or sub-scales. Infrequently occurring problems

Validation Distress Thermometer

110

may form sub-scales that are disease specific. Therefore, secondary screening is necessary in
the general cancer population to clarify the significance of symptom clusters.
In this study, Factor 6, Physical Symptoms/Neurologic Changes, suggests that central
neurologic disruption leading to insomnia and consequent fatigue and peripheral neuropathies
represent one sub-sdHe of distress. The explanation for this may be that the neuropathic
symptoms in this sample are sufficient to interfere with normal sleep patterns and lead to
fatigue. The complaints of insomnia and fatigue are commonly heard in the chemotherapy
treatment area, where the data were gathered. Alternatively, fatigue, sleep difficulties and
neuropathies are side effects or certain classes of chemotherapeutic agents especially taxanes
(Hall, 1999; Seidman et aI., 1995). This factor may be identifying these side effects. In a larger
sample, this Factor 6 may emerge as two sub-factors.
The physical problems associated with Factor 7 fever, bowel changes, problems with
urination and sexual problems represent a group of low prevalence symptoms (Portenoy, Thaler,
Kornblith, McCarthy-Lepore, Friedlander-Klar, Kiyasu et aI., 1994) that may be related in at
least two highly speculative ways. These symptoms are known side effects of radiation
treatments to the lower abdomen (Nickelson et aI., 1976; Patrick et aI., 1986). The factor may
be identifying side effects of radiation. Alternatively, both bowel and urinary changes may
result from infections. Diarrhea is symptomatic of intestinal infection and urinary burning
symptomatic of urinary tract infections. Fever is a general systemic response to infection and
sexual interest is likely to wane during acute symptomatic periods (Patrick). So, the factor may
be identifing infection.
The final group of low prevalence symptoms identified in sub scale 9, problems with the
skin, nose and mouth sores are all physical changes that result from the destruction of rapidly
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growing epithelial cells that form the surface of the skin and the linings of the nose and mouth.
The lack of specificity of cancer treatments, especially chemotherapy, for cancer cells and their
proclivity to destroy all rapidly dividing cells leads to the identification of this symptom cluster
in the sample.
Nausea, oftel1 thought to be a very prevalent problem in the cancer population, loaded as
a single symptom on a factor that lacks reliability in this sample. Schipper and colleagues
(1984) also found a serendipity factor of nausea alone when testing properties of the fourth
generation FLIC in a sample of patients with mixed cancer diagnoses. Logically, nausea was
expected to load on the PainiGI Symptoms factor. It is possible that adding more symptoms
like vomiting and lack of appetite to the DT (Holland et aI., 2000) would result in the
identification of a nausea sub-scale unrelated to other sub-scales.
The final eight-factor solution accounts for 53.56% of the sample variance. We know
that approximately 3% (Derogatis et aI., 1983) of the cancer population has personality
disorders, about 12% have major depressive disorders (Akechi et aI., 2000; Chochinov et aI.,
1994) and although there is no research to report the actual prevalence, we can assume that a
percentage have comorbid addictions. Although these problems certainly produce distress, they
are not identified by the DT (Holland et aI., 2000). Additionally, unaccounted for variance may
be related to other factors known to influence distress in cancer patients than are not accounted
for by the scale. These include attitudinal factors (Lloyd, 1979; Weisman & Worden, 1976-77),
intrusive thoughts (Baider & Denour, 1997), and degree of self monitoring (Schwartz et aI.,
1995)
The convergent validity of the DT (Holland et aI., 2000) with the three other measures of
distress is excellent in this sample. The total score of the DT is highly correlated with the total
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distress scores (P < .0001) of the FLIC (Schipper et aI.,1984; r = .641), the RSC (deHaes et aI.,
1990; ~ = .505) and the Global Severity Index (GSI) of the BSI (Derogatis, 1993;!:..= .496). The
items in the FLIC focus on the dimensions of well being or the ability to manage one's life in
the presence of physical symptoms and the interpersonal and emotional dimensions of the
illness. The RSC fotuses on a group of high prevalence physical symptoms and the emotional
distress dimensions. The highly significant correlations confirm that the DT adequately
identifies distress associated with emotional, interpersonal, functional and highly prevalent
physical symptoms. The BSI measures psychiatric symptoms. As expected, the DT total
distress score is also highly correlated with the GSI, a valid measurement of the distress
associated with emotional symptoms, of the BSI. However, it is the least perfect of the
correlations. This leads to an exploration of the differences between the distress score and the
GSI score.
It is true that cancer populations with psychiatric symptoms are distressed (Akechi et aI,

2000; Baider & DeNour, 1997; Bredart et aI., 1999; Derogatis et aI., 1979; Farber et aI., 1983;
Mahon & Casperson, 1995; Massie & Holland, 1990; Shekelle et aI., 1981), however many
distressed cancer patients may not report symptoms that indicate a psychiatric diagnosis (Craig
& Abeloff, 1974; Faller et aI., 1999; Finlay & Dunlop, 1994; Ford et aI., 1995; Jarrett, Ramirez,

Richards & Weinman, 1992; Lloyd, 1979; Rogertine et aI., 1979; Zabora et aI., 1997). If the
DT (Holland et aI., 2000) score is a sensitive measure of distress in the sample, it should
discriminate among portions of the sample with psychiatric illness and portions with
subsyndromal distress, or distress that does not fit the profile of a diagnosable psychiatric
illness. To examine this premise, the DT scores were divided into low (0-3), moderate (4-6),
and high (7-10) ranges. The subsyndromal population should have a profile of moderate
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distress score and with no relationship to the GSI (Derogatis, 1993) that is used to diagnose
psychiatric illness. In other words this cohort of patients should report distress that fails to meet
the threshold for psychiatric diagnosis. That relationship is exactly what was discovered. In this
study, subjects who scored low on the DT scored higher on the BSI GSI

(~=

- .445,2 < .0001).

Either this cohort udder reports its level of distress, or it denies the seriousness of its emotional
symptoms. A second cohort reported scores that meet or exceeded the DT cutoff for clinically
significant moderate distress, which were unrelated to the GSI scores for the same patients
.078, 2

=

(~ = -

.232). While this group reported distress, the level was not diagnostic of psychiatric

illness. So the DT was sensitive enough to detect the subsyndromal distress found in the sample.
It is hoped that identification of distressed but not psychiatrically ill patients will lead to

interventions that prevent morbidity from emotional decompensation (NCCN, 2000). The third
sample cohort reported both high DT and high GSI scores

(~=

.399,2 < .0001). This group of

patients was both distressed and psychiatrically ill.
The DT (Holland et ai., 2000) was easy to administer and score. The majority of this
sample was educated at the high school level. The reading level appears to be simple enough
for this cohort and those with more advanced education. The use of ordinary language, instead
of technical names for symptoms (e.g. "tingling in the hands and feet" instead of peripheral
neuropathy), lends to its interpretability. The level of education at which the tool becomes too
difficult to use is not known, although illiterate patients would need assistance in responding to
items. No subjects objected to its format or content. The gradation in tenths between the
integers actually allowed for 100 discriminations among distress levels and the scoring was
clear and easy. One administrative issue was discovered. In a small percentage of the cases,
patients ascribed a level of distress ranging from zero to ten to each problem. This added to the
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response burden. The information given, however, might be useful in prioritizing referrals and
beginning problem resolution addressing the most troublesome problems first. Addition of a
simple line of direction to the tool would standardize the response pattern. In further
development, the tool might be trial using either a yes/no response or an integer response format
and its performance ~nalyzed using both response sets.

Limitations of the Study

Although the results of this study are a first step toward confirming the validity of the
DT (Holland et aI., 2000) as a brief, efficient screening tool for distress in cancer populations,
the study has many limitations. The sample is one of convenience, comprised of patients from
one regional medical center in northeastern Pennsylvania. The population is largely Caucasian.
It is not known how the scale would perform in a more ethnically diverse population. All

members of the sample in this study are in active treatment with either chemotherapy or
radiotherapy. The scale may perform differently and its factor structure may vary if it were
administered in cohorts of terminal patients, those who have active disease but are receiving no
medical treatment aside from symptom management, or newly diagnosed patients before
treatment. Since the DT is designed as a general screening tool, there was no attempt to limit
the sample to one cancer diagnosis. It is probable that the instrument performs differently in
special cancer populations and that its factor structure, especially physical symptom factors,
would vary. This might be especially true of tumors that produce endocrine hormones and
those with central nervous system tumors or brain metastasis.
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The unusual gender make up of the sample undermines confidence in the description of
the level of distress and the problem distribution. We might expect a largely female population
to report more distress and a greater number of problems than a gender-balanced population at
the same stage of the disease.
The adjunctiVe medication profile of the sample was not analyzed in detail, however the
most frequently reported combination of adjunctive medications was vitamins/supplements and
pain medications. Therefore, a much larger percentage of the sample used pain medications
than indicated in the "pain medication" category of the demographic data. This data is not
sufficient in detail to lead to conclusions about the relationships among medications and reports
of distress. It is likely that this is a complex relationship, as many medications both decrease
and increase distress. For example: antibiotics may decrease fever and other signs of infection
while increasing nausea and gastrointestinal symptoms.
No cancer patients treated with surgery alone are included in the sample. The tool does
not include problems with body image, loss of strength and loss of functions that are typically
associated with surgery. It appears that the tool's performance in a surgical cancer population
would differ from its performance in the study sample.
Last, very little can be understood about how the DT performs in inpatients as the
sample was overwhelmingly outpatient in nature. No assumptions about its validity in
inpatients can be made.
Due to the cross-sectional design, no inferential conclusions can be drawn about the
relationships among stage of disease and the distress score, or about the stability of the
measurement of distress in the population.
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Recommendations for Future Research

Since the purpose of the DT is screening, it is less imp0l1ant to ask about its internal
structure, that it is to inquire about its utility as a screening devise. However, as a brief pain
measurement has clinical utility, the validation of Factor 3 with valid pain scales should be
undertaken. The nature of Factor 6 might be clarified by testing the instrument's performance
in a sample of radiation therapy clients and controlling for the physical location of the treatment
area. Future studies should also concentrate on establishing its concurrent validity in gender
neutral outpatients, inpatients and ethnically diverse populations.
More importantly, work like Roth and colleagues (1998) should continue on the use of
secondary assessments in areas of distress identified by the screening tool. This will contribute
to the tool's clinical utility.
Another area, not previously discussed, is the health care staff s reaction to the idea of
distress screening. The study met resistance as nurses were worried that asking patients about
their distress would upset them. Some nurses wanted the term "stress" substituted for the term
"distress" believing that it is more a more acceptable descriptor of emotional content than
distress. Others wanted the scale changed from zero to ten to zero to five, while retaining five
as the threshold for significant distress. Research that identifies the sources of resistance to
distress screening, and trials interventions to reduce this resistance, should be conducted.
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Conclusions

The Distress Thermometer is a reasonably sensitive, reliable and valid screening tool for
distress in outpatient general cancer patients. It meets all of the agreed upon criteria (Barg et
aI., 1994; Finlay & P,unlop, 1994; Grant et aI., 1990) for self-repOlis of distress in cancer
populations. Its wider use will contribute significantly to proper identification of distress in
large cancer populations.
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Appendix A
The Distress Thermometer

Distress Management

PRACTICE
GUIDELINES
VERSION 1.2000

During the past week, how
distressed have you been?

Please indicate your level of distress on the
thermometer and check the causes of your distress.

Extreme distress

Practical problems
-Housing
-Insurance
- Work/school
- Transportation
- Child care
Family problems
- Dealing with partner
- Dealing with children
Emotional problems
-Worry
- Sadness
- Depression
- Nervousness

No distress

From Holland et al., 2000, p. DIS 25

Spiritual/religious concerns
- Relating to God
- Loss of faith
- Other problems

Physical problems
-Pain
-'Nau'sea
- Fatigue
-Sleep
- Getting around
- Bathing/dressing
- Breathing
- Mouth sores
-Eating
-Indigestion
- Constipation/diarrhea
- Bowel changes
- Changes in urination
- Fevers
- Skin dry/itchy
- Nose dry/congested
- Tingling in hands/feet
- Feeling swollen
, - Se:<ual
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Appendix B

Rotterdam Symptom Inventory

In this questionnaire you will be ask about your symptoms. Would you please, for all symptoms
mentioned, indicate to what extent you have been bothered by it, by circling the answer most
applicable to you. 71he questions are related to the past week.

Example: Have you been bothered, during the past week, by
headaches

not at all

a little

quite a bit

very much

Have you, during the past week, been bothered by
lack of appetite

not at all

a little

quite a bit

very much

irritability

not at all

a little

quite a bit

very much

tiredness

not at all

a little

quite a bit

very much

worrying

not at all

a little

quite a bit

very much

sore muscles

not at all

a little

quite a bit

very much

depressed mood

not at all

a little

quite a bit

very much

lack of energy

not at all

a little

quite a bit

very much

low back pain

not at all

a little

quite a bit

very much

nervousness

not at all

a little

quite a bit

very much

nausea

not at all

a little

quite a bit

very much

despairing about the future

not at all

a little

quite a bit

very much

difficulty sleeping

not at all

a little

quite a bit

very much

headaches

not at all

a little

quite a bit

very much

vomiting

not at all

a little

quite a bit

very much

dizziness

not at all

a little

quite a bit

very much

decreased sexual interest

not at all

a little

quite a bit

very much

tension

not at all

a little

quite a bit

very much

abdominal (stomach) aches

not at all

a little

quite a bit

very much

anxiety

not at all

a little

quite a bit

very much
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constipation

not at all

a little

quite a bit

very much

diarrhea

not at all

a little

quite a bit

very much

acid indigestion

not at all

a little

quite a bit

very much

shivering

not at all

a little

quite a bit

very much

tingling in hands or feet
Ie

not at all

a little

quite a bit

very much

difficulty concentrating

not at all

a little

quite a bit

very much

sore mouth/pain when swallowing not at all

a little

quite a bit

very much

loss of hair

not at all

a little

quite a bit

very much

burning/sore eyes

not at all

a little

quite a bit

very much

shortness of breath

not at all

a little

quite a bit

very much

dry mouth

not at all

a little

quite a bit

very much

A number of activities is listed below. We do not want to know whether you
actually do these, but only whether you are able to perform them presently.
Would you please mark the answer that applies most to your condition of the
past week.

unable

only with
help

without help,
with difficulty

without help

care for myself

o

o

o

o

walk around the house

o

o

o

o

light housework/household jobs

o

o

o

o

climb stairs

o

o

o

o

heavy housework/household jobs

o

o

o

o

walk out of doors

o

o

o

o

go shopping

o

o

o

o

go to work

0

0

0

0

All things considered, how would you
describe your quality of life during
the past week?

0
0

0
0
0
0
0

excellent
good
moderately good
neither good nor bad
rather poor
poor
extremely poor

143

Validation Distress Thermometer

Would you please check whether you answered all the questions?
Thank you for your help

From: deHaes et aI., 1996, Appendix 2

patient number_ _ _ _ __
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Appendix C

Manitoba Cancer Treatment &Research Foundation
Functional Living Index: Cancer (FUC)
1.

Most people experience some feelings of depression at times. Rate how often you feel these
feelings.

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
2
3
4
5
6
7
Continually

1
Never
2.

3.

How well are you coping with your everyday stress?
1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
Not well
Very well
How much time do you spend thinking about your illness?

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
Constantly
Never
4.

Rate your ability to maintain your usual recreation or leisure activities

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
Able
Unable
5.

6.

Has nausea affected your daily function?
1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
Not at all
A great deal
How well do you feel today?

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
Extremely
Poor
7.

Extremely
well

Do you feel well enough to make a meal or do a minor household repair today?

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
2
3
4
5
6
7
Not
Able

1
Very
Able
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Rate the degree to which your cancer has imposed a hardship on those closest to you in the past
two weeks.

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
No
Tremendous
Hardship
Hardship
9.

Rate how often you feel discouraged about your life.

1---------------Ii;---I------------------I--------------------I------------------1---------------------1-------------------I
2
3
4
5
6
7
Never

1
Always
10.

Rate your satisfaction with your work and your jobs around the house in the past month.

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
~~

~~

Dissatisfied

Satisfied

11.

How uncomfortable do you feel today?

1-------------------1------------------1--------------------1------------------1--------7------------1-------------------1
2
3
4
5
6
7

1
Not at all

Ve~

Uncomfortable
12.

Rate in your opinion, how disruptive your cancer has been to those closest to you in the past two
weeks.

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
Totally
No
Disruptive
Disruption
13.

How much is pain or discomfort interfering with your daily activities?

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
2
3
4
5
6
7
A great deal

1
Not at all
14.

Rate the degree to which your cancer has imposed a hardship on you (personally) in the past two
weeks.

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
Tremendous
No
Hardship
Hardship
15.

How much of your usual household tasks are you able to complete?

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
2
3
4
5
6
7
All
None
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Rate how willing you were to see and spend time with those closest to you, in the past two weeks.

1-------------------1------------------1--------------------1------------------1---------------------1-------------------1
1
Unwilling

2

3

4

Manitoba Cancer Treatment &Research Foundation, 1993

5

6

7
Very
Willing
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Appendix D

Brief Symptom Inventory
Sample questions
Instructions: Below is a list of problems people sometimes have. Please read each one carefully
and blacken the circle that best describes HOW MUCH THAT PROBLEM HAS DISTRESSED
OR BOTHERED YOU DURING THE PAST 7 DAYS INCLUDING TODAY.
Not
At
All

A Moderately
little
bit

Quite Extremely
a
bit

l.

0

1

2

3

4

Nervousness or shakiness inside

2.

0

1

2

3

4

Faintness or dizziness

3.

0

1

2

3

4

The idea that someone else can control your
thoughts

4.

0

1

2

3

4

Feeling that others are to blame for most of your
trouble

5.

0

1

2

3

4

Trouble remembering things

6.

0

1

2

3

4

Feeling easily annoyed or irritated

7.

0

1

2

3

4

Feeling afraid in open spaces or on the streets

8.

0

1

2

3

4

Pains in the head or chest

9.

0

1

2

3

4

Feeling that most people cannot be trusted

From: Leonard R. Derogatis, 1993
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Symptom Distress Scale
Sample questions
How much pain you are feeling?
Worst pain)"
Have ever had--------------------------------------------------No pain
How much nausea are you experiencing?
I feel as sick
as I possibly
I do not feel
could be-------------------------------------------------------sick at all
How is your appetite?
I cannot face
My appetite is
food at all---------------------------------------------------normal for me
How do you sleep?
Could not be
Sleep as well
worse--------------------------------------------------------as ever
From: R. McCorkle and Young, 1978, p. 112

Adapted Symptom Distress Scale-2 (ASDS-2)
Sample Question
Fatigue
Frequency

Distress

a
I feel.tired.

I feel good
about the
amount of rest

1

2

3

I am occasionally I am frequently I am tired
a little tired
tired
most of
the time

4
I am very tired all
of the time

When I an tired,
Whenl am
When I am tired, When I am
it causes me
tired, it causes tired, it
it causes me
me moderate
distress as
slight distress
causes me
distress
great distress severe as it
can be

From: V. A., Rhodes, 2000, p. 51
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Appendix F
Memorial Symptom Assessment Scale
Sample Questions
During the past
week did you have I$'
any of the

no

If Yes, how often did you have it?

If yes, how severe

If yes, how much

was it?

did it distress or

following

bother you?

symptoms?
A

B

C

Dt

E

F

G

H

I

J

K

L

Vomiting

1

2

3

4

1

2

3

4

1

2

3

4

Worrying

1

2

3

4

1

2

3

4

1

2

3

4

Frequency: A = rare; B = occaslOnal; C = frequent; D = almost constant
Severity: E = slight; F = moderate; G = severe; H = very severe
Distress: I = not at all; J = a little bit; K

= quite a bit; L = very much

From: R.K. Portenoy et aI., 1994, p. 1330.
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Appendix G
Edmonton Symptom Assessment Scale
Sample Questions
On a scale of 1 to 10, with 1 being not bothered and 10 being severely bothered,how much have
the following sY111ptoms bothered you in the last

hours?

1. Pain
2. Activity

3. Nausea
4. Depression
5. Anxiety
6. Drowsiness
7. Appetite

8. Wellbeing
9. Shortness of breath

From: Edmonton Palliative Care; http://www.palliative.org/ca-essasdownload.html
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Appendix H
Instruction Sheet

1. Please complete the demographic sheet. Remember that all information that
you supply is confidential. If the item does not apply to you just mark it with N/A
,k

for not applicable.

2. There are four short tests included in your packet. Many of the same questions
will be asked on different tests. Please answer then on each test.
a. The first test is the Distress Thermometer. Please mark how distressed
you have been over the past week by drawing a line on the thermometer that
most closely represents the amount of distress. Then check the causes of
your distress on the lists.
b. The second test is the Brief Symptom Inventory. Do not complete any
identifying information. Please read the instructions, look at the example
and answer all questions.
c. The third test is the Rotterdam Symptom Checklist. Please read the brief
instructions, look at the example and answer all questions.
d. The fourth test is The Functional Living Index Cancer. Please read each
question and mark the place on the line that best describes your response to
the question.

3. When you have completed the demographic sheet and all of the tests place all
of the sheets into the envelope that was given to you. Seal the envelope and return
it to the nurse. Thank you.
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Demographic Sheet
Please check the boxes on both sides of the page that best describe you.
Male
Female

Length of Time Since this Diagnosis
3 months or less
3 months to 1 year_ __
More than 1 year _ __

Inpatient
Outpatient

Age

Highest Level of Education

18 - 30
31 - 43
44 - 55
56-67
68 - 79
79 - 91

Some High School
High School Diploma
Some College
College Degree
Graduate Degree
Trade/Teclmical School

Type of Cancer

Living Arrangements

Colon/Rectal
Breast
Ovarian
Prostate
Stomach
Lymphoma
Hodgkin's
Lung

Live Alone
Live with spouse/S.O.
Live with spouse/S.O
and dependent children
Live with parents
Live with spouse and
parents
Other

Stage of Cancer

Annual Household Income

Primary Occurrence_
Reoccurrence
Local
Metastatic

Less than $10,00o _ _
$10,001 - $25,000
$25,001 - $50,000
$50,001 - $75,000
$75,001 -$120,00o _ _
More than $120,001
(Over)
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Current Treatment

Ethnicity

Surgery
Chemotherapy
Radiation
Hormone

Caucasian
African-American
Hispanic
Other

Current Medications

Current Employment

Pain
Nausea
Fatigue
Vitamins
Hormones
Other

40 hours a week or more
21 - 39 hours a week
20 hours a week or less
Unemployed by choice
Disabled

Current Level of Pain

0_____ 1____~2 _____3_____4_____5_____6_____7
no
pam

8-----9----- 10
worst
possible
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Appendix J

Consent to Participate in Research on a New Measurement of Distress Experienced by People
with Cancer
Principal Investigator
Carole J Moretz MA., MSN
Psychology Intern
(610) 402-0551
PURPOSE: You are being asked to participate in a research study. The purpose of the study is
to complete four questionnaires in order to find out if the new "Distress Thermometer" can
measure cancer patients' distress. It will take about thirty minutes to fill out the questionnaires.
INVESTIGATORS:
Principal Investigator
Name:
Carole J. Moretz MA, MSN
Department: Intern, Cancer Support Team
John and Dorothy Morgan Cancer Center
Address:
Lehigh Valley Hospital
Cedar Crest & 1-78
Allentown, Pennsylvania 18105-1556
Phone:
(610) 402-0551
Responsible Investigator
Name:
Department:
Address:

Phone:

Stephanie Felgoise Ph.D
Licensed Clinical Psychologist
Assistant Director of Research
Philadelphia College of Osteopathic Medicine
4190 City Avenue
Philadelphia, Pennsylvania 19131-1693
(215) 871-6543

RISKS: You will be asked to write the answers to many questions. It takes about thirty minutes
to fill out all of the testing materials. Reading and answering these materials may be tiring. The
questions may be asked many times and may be upsetting to some people. You may realize that
you have a problem that you did not know about or were able to ignore before. If this happens
you might worry about the problem or become upset. If you get upset, tell your nurse or call
(610) 402-CARE for information about how to get help.
BENEFITS: You may not benefit directly from this research. The research may benefit other
cancer patients in the future by helping hospital staff to identify cancer patients who need help
to solve problems that cause them to be upset.

Validation Distress Thermometer

156

COMPENSATION FOR INJURY OR ILLNESS: You understand that in the event of physical
or psychological injury, treatment will be provided by Lehigh Valley Hospital. The costs of
treatment will be charged to you or your insurance company. Lehigh Valley Hospital will not
be responsible for providing either financial compensation or free medical treatment.
CONFIDENTIALITY STATEMENT: Any information about you or your treatment obtained
from this research-in~luding your medical history, personal data, and written test results-will
be kept confidential and never identified in any report. Should results of this study be reported
in medical or psychological journals or at meetings, the names of all participants will remain
anonymous. Only authorized representatives, Carole Moretz the principle investigator, Dr.
Stephanie Felgoise her supervisor, and members of the research committee will have access to
the records relating to this research. All information examined will be coded and kept
confidential.
OPTION OF WITHDRAWAL WITHOUT PREDJUDICE: You can decide not to participate in
this study or can drop out at any time. Your health care will not be affected if you decide not to
be in the study, or if you decide to drop out. Your participation is entirely voluntary. If you
want to be in the study, we are required by federal regulations (45CFR 46) to have you read the
following paragraph and sign your name below it.
I have been given the opportunity to ask questions, and all of my questions have been
answered. I consent to participate in this study. I understand that ifI have further questions
about this study I may contact Carole Moretz by telephoning (610) 402-0551, her supervisor Dr.
Stephanie Felogise at (215) 871-6543 or want information regarding my rights as a research
subject, I may contact Thomas Wasser, Ph.D, Institutional Review Board Administrator at
Lehigh Valley Hospital by telephoning (610) 402-2525

Patient Signature (or Patient's Representative)

Date

Investigator Signature

Date

Witness Signature

Date

